GB2039478A - Derivatives of mercaptoacyl pyrrolidines or piperidines - Google Patents
Derivatives of mercaptoacyl pyrrolidines or piperidines Download PDFInfo
- Publication number
- GB2039478A GB2039478A GB7942991A GB7942991A GB2039478A GB 2039478 A GB2039478 A GB 2039478A GB 7942991 A GB7942991 A GB 7942991A GB 7942991 A GB7942991 A GB 7942991A GB 2039478 A GB2039478 A GB 2039478A
- Authority
- GB
- United Kingdom
- Prior art keywords
- hydrogen
- lower alkyl
- methyl
- compound
- oxopropyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D497/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms
- C07D497/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D497/10—Spiro-condensed systems
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Heart & Thoracic Surgery (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Abstract
Mercapto acyl compounds, having hypotensive activity, have the formula:- <IMAGE> or are salts thereof, wherein R is hydrogen or lower alkyl, R1 and R2 are various defined organic groups or R1 and R2 together complete a ring, X1 and X2 are oxygen or sulphur, one of p and q is 1 and the other is 1 or 2, R3 and R4 are hydrogen lower alkyl, lower alkyl thio, -(CH2)n SH or halo lower alkyl, (n being from 1 to 3), R6 is hydrogen or (when R3 is lower alkyl) lower alkyl, m is 0, 1 or 2 and R5 is hydrogen or a protecting group.
Description
SPECIFICATION
Derivatives of mercaptoacyl prolines
This invention provides new derivatives of mercaptoacyl prolines and pipecolic acids of formula I and salts thereof
R and R6 are independently selected from hydrogen and lower alkyl provided that Re is lower alkyl only if
R3 is also lower alkyl.
R3 and R4 are independently selected from hydrogen, lower alkyl, lower alkylthio -(CH2)n-SH, and halo substituted lower alkyl.
X1, X2 and X3 are independently selected from oxygen and sulfur.
R, and R2 are independently selected from lower alkyl, lower alkenyl, lower alkynyl, cycloalkyl, halo substituted lower alkyl, hydroxy substituted lower alkyl,
or R1 and R2 join in a polymethylene chain to complete an unsubstituted or substituted 5- or6- membered ring.
When R1 and R2 are joined together in a polymethylene chain of 2 or 3 carbons, these cyclic ketal and thioketals can be represented as follows:
wherein t is 2 or 3 and Rg and R10 are both hydrogen, both lower alkyl, or one is hydrogen and the other is lower alkyl, halo substituted lower alkyl, hydroxy substituted lower alkyl,
Preferably, only one carbon of the polymethylene chain will be substituted.
R7 is hydrogen, lower alkyl of 1 to 4 carbons, especially methyl, lower alkoxy of 1 to 4 carbons, especially methoxy, lower alkylthio of 1 to 4 carbons, especially methylthio, chloro, bromo, fluoro, trifluoromethyl, or hydroxy.
R5 is hydrogen, a hydrolyzably removable protecting group, a chemically removable protecting group, or when Ra and R4 are otherthan-lCH2)n-SH a sulfide of the formula
m is zero, one, or two.
n is one, two or three.
p and q are each one or two provided that both are not two.
The asterisk in the above formula indicates a center of asymmetry in the ring. In the case of proline, i.e., p and q are both one, this center is in the
L-configuration. In the case of pipecolic acid, i.e., one of p and q is two, this center is in the D, L or L-configu ration.
Asymmetric centers can also be present in the mercaptoacyl sidechain depending upon the definition of R3, R4 and R6. Another assymetric center may also be present in the ring when X1-R1 and X2-R2 are different. The products can accordingly exist in stereoisomeric forms or as racemic mixtures thereof. All of these are within the scope of the invention. The synthesis described below can utilize the racemate or one of the enantiomers as starting materials. When the racemic starting material is used in the synthesis procedure, the stereoisomers obtained in final product can be separated by conventional chromatographic or fractional crystallization methods. Preferably, if there is an asymmetric center in the mercaptoacyl sidechain, it is in the
D-configuration.
This invention in its broadest aspect relates to the mercaptoacyl derivatives of proline and pipecolic acid having formula I above and to salts thereof, to compositions containing such compounds and to the method for using such compounds as antihypertensive agents. This invention is also directed to certain novel intermediates useful in the preparation of compounds of formula 1.
The term lower alkyl as used in defining the symbols R, R1, R2, Rg, R4, and Re are straight or branched chain hydrocarbon radicals having up to seven carbons, for example, methyl, ethyl, propyl, isopropyl, butyl, isobutyl, t-butyl, pentyl, isopentyl, etc. The preferred lower alkyl groups are up to four carbons with methyl and ethyl being most preferred. Similarly, the terms lower alkoxy and lower alkylthio refer to such lower alkyl groups attached to an oxygen or sulfur.
The term cycloalkyl refers to saturated rings of 3 to 7 carbon atoms with cyclohexyl being most preferred.
The term halo substituted lower alkyl refers to such lower alkyl groups described above in which
one or more hydrogens have been replaced by chloro, bromo orfluoro groups such as trifluoromethyl, pentafluoromethyl, 2,2,2 - trich
Certain of the chemical formulae appearing in the printed specification were submitted in formal form after the date
of filing.
loroethyl, chloromethyl, bromomethyl, etc.
The term hydroxy substituted lower alkyl refers to such lower alkyl groups described above in which one hydrogen has been replaced by a hydroxy group such as hydroxymethyl, 2 - hydroxyethyl, etc.
The term lower alkenyl as used in defining the symbols R1 and R2 are mono-saturated straight or branched chain hydrocarbon groups of from 2 to 7 carbons such as ethenyl, propenyl, isopropenyl, butenyl, and the like. The lower alkenyl groups are straight or branched chain hydrocarbon groups of from 2 to 7 carbons having one triple bond, e.g., propargyl. The referred lower alkenyl groups are from 2 to 5 carbons and the preferred lower alkynyl groups are from 2 to 4 carbon atoms.
The term hydrolyzably removable protecting group employed in defining R5 refers to a group that can be removed by conventional hydrolysis or amonolysis. Acyl groups of the formula
are suitable for this purpose wherein Re can be lower alkyl of 1 to 7 carbons, lower alkyl substituted with one or more chloro, bromo or fluoro groups, -(CH2), - cycloalkyl, an aryl group such as
wherein r is zero, one, two or three, and R7 and X3 are as defined above. Preferred groups are the lower alkanoyl groups having up to four carbons, especially acetyl, and benzoyl.
The term chemically removable protecting group employed in defining R5 refers to groups such as p methoxybenzyl, p- methoxybenzyloxyca rbonyl, trityl, t- butoxycarbonyl, etc. These groups can be removed after the completion of the acylation reaction by various means depending upon the definition of X1-R1 and X2-X2 such as by treatment with trifluoroacetic acid and anisole, sodium and liquid ammonia, or mercurictrifluoroacetate.
Preferred compounds of formula I are the L - proline containing derivative, i.e., p and q are both one, and R is hydrogen.
With respect to the mercaptoacyl sidechain, preferred as final products are those compounds wherein R5 is hydrogen; m is zero or one; R4 is hydrogen; and Ra and Re are both lower alkyl of 1 to 4 carbons, especially both methyl, or Re is hydrogen and Ra is hydrogen, lower alkyl of 1 to 4 carbons, especially methyl, trifluoromethyl, methylthio, or mercaptomethyl. Also preferred as both intermediates and final products are the above sidechains wherein R5 is lower alkanoyl or 1 to 4 carbons, especially acetyl, or benzoyl.
Especially preferred as the final products are the compounds of formula I having the mercaptoacyl sidechain wherein R5 is hydrogen; m is one; R4 and
R6 are hydrogen; Ra is methyl; and the asymmetric carbon atom to which Ra is attached is in the
D-configuration.
Preferred compounds with respect to the substituents on the proline ring are those wherein R, and R2 are independently selected from lower alkyl of 1 to 4 carbons, especially methyl or ethyl;
and R7 is hydrogen, methyl, methoxy, methylthio, Cl,
Br, F, trifluoromethyl, or hydroxy; or X,-R, and X2-R2 join to form
wherein Re and R10 are both hydrogen or both lower alkyl of 1 to 4 carbons, especially both hydrogen or both methyl, or R9 is hydrogen and R10 is lower alkyl of 1 to 4 carbons, especially methyl hydroxy substituted lower alkyl of 1 to 4 carbons, especially hydroxymethyl, or halo substituted lower alkyl, especially trifluoromethyl.
Most preferred compounds with respect to the substituents on the proline ring are those wherein X and Xa are the same especially those wherein X1-R1 and X2-R2 are both methoxy or both ethoxy or X1-R and X2-R2 join together to form
The compounds of formula I are obtained by coupling the substituted proline or pipecolic acid of the formula
with an acid or its chemical equivalent of the formula
wherein R5, is hydrogen, a hydrolyzably or chemically removable protecting group to yield the product of the formula
This reaction can be effected in the presence of a coupling agent such as dicyclohexylcarbodiimide or the like, or the acid can be activated by formation of its mixed anhydride, symmetrical anhydride, acid halide, active ester or use of Woodward reagent K, N - ethoxycarbonyl - 2 - ethoxy - 1,2 - dihydroquinoline or the like. Four a review of the methods of acylation, see Methoden der Organishchen Chemie (Houben-Weyl), Vol. XV, part II, page 1 etseq. (1974).
Preferably, the acid halide, especially the acid chloride, of formula Ill is reacted with the acid formula II.
If the proline or pipecolic acid of formula II is reacted in the ester form the resulting ester product of formula IV, i.e., R is alkyl, can be converted to the free acid, i.e., R is hydrogen, by conventional means.
For example, if R is ethyl this ester protecting group can be removed by saponification.
The product of formula IV is preferably isolated and purified by crystallization, e.g., by forming the dicyclohexylamine salt and then converting the salt to the free acid form by treatment with an aqueous solution of an acid, such as potassium acid sulfate.
The product of formula IV bearing the acyl group R8-CO- can be converted to the products of formula I wherein R5 is hydrogen by conventional hydrolysis or by ammonolysis.
The products of formula I wherein Ra and R4 are otherthan-(CH2)n-SH and R5 is
are obtained by directly oxidizing with iodine a product of formula I wherein R5 is hydrogen.
The esters of formula I wherein R is lower alkyl can be obtained from the carboxylic acid compounds, i.e., wherein R is hydrogen, by conventional esterification procedures, e.g., by esterification with a diazoalkane such as diazomethane, a 1 - alkyl - 3 - p tolyltriazene, such as 1 - n - butyl - 3 - p - tolyltriazene, or the like.
The disubstituted prolines or pipecolic acids of formula II wherein X1-R1 and X2-R2 are the same, can be obtained by reacting an N-protected keto compound of the fomula
wherein Cbz represents carbobenzyloxy with an alcohol orthiol having the formula
(Vl) R,-X,-H in the presence of an orthoformate orthioformate of the formula HC(X,-Ri)s and an acid such as concentrated sulfuric acid or p - toluenesulfonic acid. This reaction can be effected in an inert organic solvent such as benzene, acetic acid, ether, cyclohexane or the like, preferably with heating, e.g., at about reflux temperature. See Buehler et al., Survey of Organic
Syntheses (Wiley & Sons, 1977) Vol. 1, pages 516-519.The product of this reaction is the
N-protected intermediate of the formula
The N-protected intermediate of formula VII can be treated with a molar equivalent of an alcohol of thiol of the formula (veil) R2-X2-H according to the conditions described above to yield the intermediate
By employing a molar excess of the alcohol orthiol of formula Vll one obtains the intermediate
The N-protecting group can then be removed by conventional procedures, for example, when X1 and
X2 are both oxygen by hydrogenolysis in the presence of palladium carbon catalyst or when either or both X1 and X2 are sulfur by treatment with HBr and acetic acid to yield the disubstituted compounds offormula II.
Similarly, the spiro compounds of formula II (i.e.,
R1 and Ra are joined together in a polymethylene chain) can be obtained by reacting the keto compound of formula V with the alcohol orthiol of the formula
wherein Rg, R10, and tare are defined above in the presence of an acid such as p - toluenesulfonic acid, to yield the intermediate
Alternatively, the disubstituted compound of formula VII can be treated directly with a molar excess of the alcohol orthiol of formula Xl to yield the intermediate of formula XII. This procedure is particularly useful when Rg and R1, are either or both other than hydrogen.
As described above, the N-protecting group can then be removed to yield the spiro compounds of formula II.
As an alternative procedure, the introduction of the X1-R1 and X2-R2 groups can be effected later in the sequence. According to this modification, the protected keto compound of formula V is treated to remove the protecting group, e.g., with hydrogen bromide, resulting in an intermediate having the formula
which is then acylated with the acid, preferably the acid halide, of formula Ill to yield the compound of the formula
The groups X1-R1 and X2-R2 or the spiro group
can then be introduced at this point by the procedures described above to yield the product of formula IV.
Reference is also made to the following publications for additional illustrative methodology for producing starting materials and intermediates: U.S.
Patents 4,046,889,4,105,776, 4,154,935 and 4,116,962; Can. J. Biochem. & Physiol.37, 584 (1959); J.A.C.S. 79, 189(1957); J. Med. Chem. 21,445 (1978); Aus. J. Chem.20, 1493-1509(1967); Buehler et al., Survey of Organic Syntheses (Wiley & Sons, 1977), Vol. 1, pages 516-519, Vol.2 pages 461-470;
Chem. Pharm. Bull., Tokyo 26,2209 and 2217 (1978);
Can. J. Chem. 47,860 (1969); J. Amer. Chem. Soc., 80,6350 (1958); Harrison et al., Compendium of
Organic Synthetic Methods, (Wiley-lnterscience,
New York, 1971), pages 449456; J. Amer. Chem.
Soc., 79, 192 (1956); Bull. Soc. Chem., 1965(8) pages 2253-2259; J. Org. Chem.25, p.521-530(1960).
The procedures illustrated therein can be utilized as general methods for the synthesis of compounds and separation of isomers which can be utilized in the invention described in this application. Additional illustrative details are found in the examples which serve as models for the preparation of other members of the group.
The compounds of this invention form basic salts with a variety of inorganic or organic bases. The salt forming ion derived from such bases can be metal ions, e.g., aluminium alkali metal ions, such as sodium or potassium, alkaline earth metal ions such as calcium or magnesium, or an amine salt ion, of which a number are known forthis purpose, for example aralkylamines like, dibenzylamine, N,N dibenzylethylenediamine, lower alkylamines like methylamine, t- butylamine, procaine, lower alkylpiperidines like N - ethylpiperidine, cycloalkylamines, like cyclohexylamine or dicyclohex ylamine, 1 - adamantanamine, benzathine, or salts derived from amino acids like arginine, lysine or the like. The physiologically acceptable salts like the sodium or potassium salts can be used medicinally as described below and are preferred.These and other salts which are not necessarily physiologically acceptable are useful in isolating or purifying a product acceptable for the purposes described below, as illustrated with the dicyclohexylamine salt in the examples. The salts are produced by reacting the acid form of the compound with an equivalent of the base supplying the desired basic ion in a medium and then lyophilizing. The free acid form can be obtained from the salt by conventional neutralization techniques, e.g., with potassium bisulfate, hydrochloric acid, etc.
The compound of formula I wherein Re is hydrogen,
or the disulfidetype substituent, especially wherein R5 is hydrogen, are useful as hypotensive agents. They inhibit the conversion of the decapeptide angiotensin I to angiotensin II and, therefore, are useful in relieving angiotensin related hypertension.
The action of the enzyme renin on angiotensinogen, a pseudoglobulin in blood plasma, produces angiotensin I. Angiotensin I is converted by angiotensin converting enzyme (ACE) to angiotensin
II. The latter is an active pressor substance which has been implicated as the causative agent in various forms of hypertension in various mammalian species, e.g., rats and dogs. The compounds of this invention intervene in the angiontensinogen (Renin) oangiotensin I ~(ACE) oangiotensin II sequence by inhibiting angiotensin converting enzyme and reducing or eliminating the formation of the pressor substance angiotensin II. Thus by the administration of a composition containing one, or a combination of compounds of formula I angiotensin dependent hypertension in the species of mammal suffering therefrom is alleviated.A single dose, or preferably two to four divided daily doses, provided on a basis of about 0.1 to 100 mg. per kilogram of body weight per day, preferably about 1 to 15 mg.
per kilogram of body weight per day is appropriate to reduce blood pressure. The substance is preferably administered orally, but parenteral routes such as the subcutaneous, intramuscular, intravenous or intraperitoneal routes can also be employed.
The compounds of this invention can also be formulated in combination with a diuretic for the treatment of hypertension. A combination product comprising a compound of this invention and a diuretic can be administered in an effective amount which comprises (for a 70 kg. mammal) a total daily dosage of about 30 to 600 mg., preferably about 30 to 300 mg., of a compound of this invention, and about 15 to 300 mg., preferably about 15 to 200 mg. of the diuretic, to a mammalian species in need thereof.
Exemplary of the diuretics contemplated for use in combination with a compound of this invention are the thiazide diuretics, e.g., chlorthiazide, hydrochlorthiazide, flumethiazide, hydroglumethiazide, benzdroflumethiazide, methchlothiazide, trichlormethiazide, polythiazide or benzthiazide, as well as ethacrynic acid, ticrynafen, chlorthalidone, furosemide, musolimine, bumetanide, triamterene, amiloride and spironolactone, and salts of such compounds.
The compounds of formula I can be formulated for use in the reduction of blood pressure in compositions such as tablets, capsules or elixirs for oral administration or in sterile solutions or suspensions for parenteral administration. About 10 to 500 mg. of a compound or mixture of compounds of formula I is compounded with a physiologically acceptable vehicle, carrier, excipient, binder, preservative, stabilizer, flavor, etc., in a unit dosage form as called for by accepted pharmaceutical practice. The amount of active substance in these compositions or preparations is such that a suitable dosage in the range indicated is obtained.
Illustrative process details are set forth in the following examples for the various reactions. These examples are preferred embodiments and also serve as models for the preparation of other compounds of this invention. The temperatures are given in degrees on the centigrade scale.
Example 1 [7 ssj -7 - (Acetylthio) - 2 - methyl - 1- oxop- ropyl] - 1,4 - dioxo -7 - azaspiro[4.4]nonane - 8 carboxylic acid a) N - Carbobenzyloxy -4- hydroxy - L - proline
26.5 g. (0.20 mole) of 4 - hydroxy L - proline and 32.8 ml. (0.23 mole) of benzyl chloroformate are reacted in 200 ml. of water and 100 ml. of acetone in the presence of 20 g. (0.02 mole) of potassium bicarbonate and 69.2 g. (0.50 mole) of potassium carbonate and worked up with 90 ml. of concentrated hyd
rochloric acid as described in Can. J. Biochem. & BR<
Physiol. 37 584 (1959) to obtain N - carbobenzyloxy 4- hydroxy- L- proline.This product is reacted with cyclohexylamine to form the cyclohexylamine salt yield 69 g., m.p. 193-195". The salt (34 g.) is neutralized with N - hydrochloric acid to obtain 27 g. of free acid as a colorless glass[o;1260 -700r (c, 1% in chloroform).
b) N - carbobenzyloxy - 4 - keto - L - proline 21.5 g. (0.81 mole) of N - carbobenzyloxy - 4 - hydroxy - L - proline is oxidized in 1.2 liters of acetone with 83 ml. of 8N chromic acid in sulfuric acid as described in J.A.C.S. 79, 189 (1957). In order to facilitate the subsequent filtration of chromium salts, 30 g. of Celite (diatomaceous earth) is added to the acetone solution before introduction of the oxidizing agent. An air stirrer is employed. The reaction mixture is filtered and the acetone filtrate is concentrated to approximately 300 ml. before diluting with 1 liter of chloroform.The solution is washed with 300 mi. of saturated sodium chloride (four times), dried (MgSO4), filtered and the solvent evaporated to give
N - carbobenzyloxy - 4 - keto - L - proline (22.8 g.) which is crystallized from ether (50 ml.) - hexane (150 ml.) to obtain 17.2 g. (81%) of product, m.p. 99-101q [a]26D +17 (c,1% in chloroform).
c) N - Carbobenzyloxy - 4,4 - ethylenedioxy - L - proline
A stirred mixture of 12.8 g. (0.049 mole) of N carbobenzyloxy - 4 - keto - L - proline, 53 ml. (0.095 mole) of ethylene glycol, and 0.35 g. of p - toluene sulfonic acid H20 in 1.311. of benzene is heated and the resulting solution is refluxed for 7 hours (water formed is collected in a Dean-Stark apparatus). After standing overnight at room temperature, the lower glycol layer is separated and the benzene solution is washed with 150 ml. of saturated sodium chloride, dried (MgSO4), and the solvent evaporated to give 14.6 g of N - carbobenzyloxy - 4,4 - ethylenedioxy - L - proline as a syrupy residue. The latter is dissolved in 60 ml. of ethanol, filtered, treated with 5 g. of cyclohexylamine, and diluted with ether.On seeding and rubbing, the crystalline cyclohexylamine salt separates; weight after cooling overnight, 9.0 g., m.p. 179-180" (s.173 ). The material is recrystallized from acetonitrile, m.p. 182-184" (s.
179 ), [a]ae,a -21' (c, 1% in EtOH).
The cyclohexylamine salt (8.4 g.) is suspended in 40 ml. of ethyl acetate, stirred, cooled, and treated with 40 ml. of 1 N hydrochloric acid. The layers are separated, the aqueous phase extracted with additional ethyl acetate (3 x 40 ml.), the combined organic layers are dried (MgSO4), and the solvent evaporated, finally at 0.2 mm. The syrupy residue which begins to crystallize is rubbed under ether and the ether evaporated to give 6.4 g. (42%) of nearly colorless N - carbobenzyloxy - 4,4 - ethylenedioxy - L - proline, m.p. 101-103" (s. 98"),[o;lZg -340 (c,1% in
CHCla).
d) 4,4 - Ethylenedioxy - L - proline
A solution of 3.2 g (0.0104 mole) of N - carbobenzyloxy - 4,4 - ethylenedioxy - L - proline in 100 ml. of
methanol-water (2:1) is treated with 1 g. of 5%
palladium-carbon and shaken on the Parr hyd
rogenator for 6 hours. The catalyst is filtered off
under nitrogen, washed with methanol, and the
combined filtrates evaporated, finally at 0.1-0.2 mm, to give 1.7 g. (94%) of colorless solid, 4,4 ethylenedioxy - L - proline; m.p. 245-247" (dec.); [a]26D -32 (c, 0.5% in 1:1 MeOH-H2O).
e)[7 (S), 8Sj - 7- [3- (Acetylthio)-2-methyl- 1
oxopropyl] 1,4- dioxo -7- azaspiro[4.4]nonane -8
carboxylic acid
A stirred solution of 3.2 g. of 4,4 - ethylenedioxy
L - proline (0.0185 mole) in 50 ml. of water is cooled to 5" and treated portionwise with solid sodium car
bonate to pH 8.5. Then while continuing stirring and
cooling, a solution of 3.7 g. (0.020 mol.) of D - 3
acetylthio - 2 - methylpropanoyl chloride in 5 ml. of
ether is added portionwise while maintaining the pH
at 8.5 with 25% sodium carbonate solution (about 14
ml.).After 1- hours, the solution is treated with 50
ml. of ethyl acetate, stirred, cooled, acidified carefully with hydrochloric acid (1 :1) to pH 2.0, saturated with sodium chloride and the layers are separated.
The aqueous phase is extracted with additional ethyl acetate (3 x 50 ml.), the combined organic layers are dried (MgSO4) and the solvent evaporated finally at 0.2 mm. The solid residue is rubbed under ether and the evaporation repeated to obtain 5.9 g. (100%) of[7 (S),8S] - 7 - [3 - (acetylthio) - 2 - methyl - 1 - oxopropyl] - 1,4 - dioxo - 7 - azaspiro[4.4jnonane - 8 carboxylic acid; m.p.108-111 .
The product is converted to the dicyclohexylamine salt with 3.4 g. of dicyclohexylamine in 70 ml. of ethyl acetate. On seeding and rubbing, the crystalline salt precipitates and is recrystallized from 95 ml.
of acetonitrile; yield 6.7 g., m.p. 187-189" (s. 1840).
[0(]'5, -590 (c, 1% in EtOH).
The dicyclohexylamine salt is converted to the free
acid by suspending it in ethyl acetate and treating
with 75 ml. of 10% potassium bisulfate and stirring
until two layers are obtained. After separating, the
aqueous phase is extracted with ethyl acetate (4 x 75
ml.) the organic layers are combined, dried (MgSO4)
and the solvent is evaporated to give 4.1 g. of colorless [7 (S), 8S] - 7 - [3 - (acetylthio) - 2 - methyl - 1 oxopropyl] - 1,4 - dioxo - 7 - azaspiro[4.4] nonane - 8 carboxylic acid, m.p. 120-122" (s.117 ) [a]25D - 118 (c, 1% in EtOH).
Example 2 [7(S)-8S]-7-(3-Mercapto-2-methyl- 1 - oxopropyl) - 1,4- dioxo -7- azaspiro[4.4]nonane -8carboxylic acid
Argon is passed through a cold solution of 8.5 ml.
of concentrated ammonium hydroxide in 20 ml. of water. 4.0 g. (0.013 mole) of[7 (S), 8S] - 7 - [3 (acetylthio) - 2- methyl - 1 - oxopropyl] - 1,4 - dioxo 7 - azaspiro - [4.4] nonane - 8 - carboxylic acid from
Example 1e are then added and the mixture is stirred in an ice bath for a few minutes and then a room temperature under argon for two hours. The solution is treated with 30 ml. of ethyl acetate, cooled, stirred, and acidified with 16 ml. of of hydrochloric acid (1 :1).
The layers are separated, the aqueous phase is extracted with additional 30 ml. of ethyl acetate (twice), the ethyl acetate extracts are combined, dried (MgSO4) and the solvent evaporated to give [7 (S),8S] - 7 - (3 - mercapto - 2 - methyl - 1 - oxopropyl) - 1,4 - dioxo - 7 - azaspiro[4.4] nonane - 8 - carboxylic acid as a solid residue. The product is rubbed under ether and the evaporation is repeated.The product is then triturated with 30 ml. of hexane, cooled for one hour, filtered under argon and dried in vacuo to give
2.7 g. of colorless solid [7 (S),8Sg - 7 - (3 - mercapto
2 - methyl - 1 - oxopropyl) - 1,4 - dioxo - 7 - azas- piro[4.4]nonane - 8 - carboxylic acid, m.p. 131-133" (S.125 ),[a]25D -66 (c,1% in EtOH).
Example 3 (SI -7-[(3-Acetylthio)- 2-methyl-l- oxopropyl]- 4,4 - dimethoxy - L - proline a) N - Carbobenzyloxy -4,4- dimethoxy - L - proline, methyl ester
A stirred solution of 7.8 g. (0.03 mole) of N - car
bobenzyloxy - 4 - keto - L - proline from Example 1 in
60 ml. of methanol is treated with 96 ml. of trimethyl
orthoformate, followed by 0.6 ml. of concentrated
sulfuric acid and allowed to stand overnight at room temperature.
The pale yellow solution is stirred, treated with 1.5
g. of potassium carbonate, followed by 30 ml. of water and the bulk of the solvent is removed on a
rotary evaporator to give a syrupy residue which is shaken with 30 ml. of water and 30 ml. of chloroform. After separating the layers the aqueous
phase is extracted with additional chloroform (3 x 30
ml.) and the combined organic layers are washed with 45 ml. of saturated sodium chloride solution and dried (MgSO4). Evaporation of the solvent yields 8.4 g (88%) of N - carbobenzyloxy - 4,4 - dimethoxy L - proline, methyl ester.
b) N - Carbobenzyloxy -4,4- dimethoxy - L - proline
The ester (8.4 g., 0.026 mole) from part a is dissol
ved in 80 ml. of methanol, treated dropwise at - 1 to 4" with 18 ml. (0.036 mole) of 2N sodium hydroxide
kept at 0" for one hour, and at room temperature
overnight. After removing about one half of the sol
vent on a rotary evaporator, the solution is diluted with 150 ml. of water, washed with 100 ml. of ether
(wash discarded), acidified while cooling with 63 ml.
of 1:1 hydrochloric acid to pH 2, and extracted with ethyl acetate (4 x 750 ml.). The combined extracts are washed with 50 ml. of saturated sodium chloride solution, dried (MgSO=), and the solvent evaporated to give 8.0 g. of a pale yellow viscous oil. The oil is dissolved in 35 ml. ethanol, treated with 3.0 g.
of cyclohexylamine in 10 ml. of ethanol and diluted to 500 ml. with ether. On seeding and rubbing, the crystalline N - carbobenzyloxy - 4,4 - dimethoxy - L proline cyclohexylamine salt separated; weight after cooling overnight, 7.0 g., m.p. 157-159" (s,151) [a]2eD -34" (c, 1% in EtOH). This material is recrystallized from 100 ml. of acetonitrile to give the salt as a colorless solid, m.p. 158-160" (s, 154') [a]26D -33" (c, 1% in
EtOH).
The N - carbobenzyloxy - 4,4 - dimethoxy - L - proline cyclohexylamine salt is suspended in 40 ml. of ethyl acetate, stirred and treated with 25 ml. of 1 N hydrochloric acid. When two clear layers are obtained they are separated, the aqueous phase is extracted with additional ethyl acetate (3 x 40 ml.), the combined organic layers are dried (MgSO4), and the solvent evaporated, finally at 0.2 mm and 40 to yield 7.2 g (70%) of N - carbobenzyloxy - 4,4 dimethoxy - L - proline as a pale yellow viscous syrup.
c) 4,4 - Dimethoxy - L - proline
A solution of N - carbobenzyloxy - 4,4 - dimethoxy - L - proline (72 g., 0.022 mole) in 210 ml. of methanol - water (2:1) is treated with 2.3 g. of 5% palladium carbon and shaken on a Parr hydrogenatorfor 6 hours. The catalyst is filtered off under nitrogen, washed with methanol, and the combined filtrates are evaporated, finally at 0.1-0.2 mm., to give a partly crystalline residue. This residue is taken up in 200 ml. of methanol and the evaporation repeated. When the solid is rubbed under ether (evaporation again repeated) there is obtained 3.6 g. (95%) of nearly colorless 4,4 - dimethoxy - L - proline, m.p. 192-194" (dec.); [a]25D -47 (c,1% in MeOH).
A sample crystailized from methanol-ether is colorless and melts at 197-198" (dec.); [a]2en -49' (c, 1% in MeOH).
d) (S) - 1- [3 - (Acetylthio) - 2-methyl - 1- oxopropyl] -4,4- dimethoxy-L proline Astirredsolution of 3.3 g. (0.019 mole) of4,4- dimethoxy - L - proline in 50 ml. of water is cooled to 5" and brought to pH 8.5 by the addition of 25% sodium carbonate solution (w/v). Then while continuing stirring and cooling, a solution of 3.8 g.
(0.021 mole) of D - 3 - acetylthio - 2 - methylpropanoyl chloride in 5 ml. of ether is added portionwise while maintaining the pH at 7.5-8.5 by dropwise addition of 25% sodium carbonate solution. When the pH has stabilized at 8.2-8.4 (after about 15 minutes), stirring and cooling is continued for a total of one hour. The solution is then washed with 50 ml. of ethyl acetate (was discarded, layered over with 50 ml. of ethyl acetate, cooled, stirred, acidified carefully with 1:1 hydrochloric acid to pH 2.0, saturated with sodium chloride, and the layers separated. The aqueous phase is extracted with additional ethyl acetate (3 x 50 ml.), the combined organic layers are dried (MgSO4), and the solvent evaporated, finally at 0.2 mm, to give 6.7 g. of syrupy product.This syrup is treated in 70 ml. of ethyl acetate with 3.9 g. of dicyclohexylamine to give 6.5 g. of colorless (S) - 1 - [3 - (acetylthio) - 2 - methyl - 1 oxopropyl] - 4,4 - dimethoxy - L - proline dicyclohexylamine salt in crops (3.1 g. and 3.4 g.), m.p. 158-160" (s, 145"). [a]26D -71 (c, 1% in EtOH).
Following recrystallization from 20 ml. of hot ethyl acetate - 60 ml. of hexane, the colorless solid salt weighs 6.0 g., m.p. 158-166" (s, 155'),[a]26n -69' (c,
1% in EtOH).
The dicyclohexylamine salt is converted to the free acid by suspending 5.0 g. in 50 ml. of ethyl acetate, cooling and treating with 60 ml. of 10% potassium bisulfate solution to give 2 clear layers. Afterseparat- ing, the aqueous phase is extracted with ethyl acetate (3 x 50 ml.), the combined organic layers are dried (MgSO4), and the solvent evaporated, finally at 0.1-0.2 mm. and 45 to give 4.1 g. (69%) of (S) - 1 - [3 (acetylthio) - 2 - methyl - 1 - oxopropyl] - 4,4 dimethoxy - L - proline as a viscous, almost glass-like material [of]25D -112 (c,1% in EtOH).
Example 4 (S)- 1 - (3-Mercapto -2-methyl-i 1-oxopropyl)-4,4 - dimethoxy - L - proline
Argon is passed through a cold solution of 8.5 ml.
of concentrated ammonium hydroxide in 20 ml. of water for 0.25 hour. The latter is then added while cooling and under a blanket of argon to 4.1 g. (0.013
mole) of (S) - 1 -[3 - (acetylthio) - 2 - methyl - 1 oxopropyl] - 4,4 - dimethoxy - L - proline and the mixture is swirled in an icebath until a pale yellow solution is obtained (about 15 minutes). Stirring under argon is continued at room temperature for an additional 2 hours, then the solution is extracted with 30 ml. of ethyl acetate (this and subsequent operations are carried out as much as possible under
an argon atmosphere). The aqueous layer is cooled,
stirred, layered over with 30 ml. of ethyl acetate, and
acidified portionwise with approximately 16 ml. of
1:1 hydrochloric acid.The layers are separated, the
aqueous phase is extracted with additional ethyl acetate (3 x 30 ml.), the combined ethyl acetate layers
are dried (MgSO4) and the solvent evaporated to
give 3.5 g. (100%) of (S) - 1 - (3 - mercapto - 2 - methyl
- 1 - oxopropyl) - 4,4 - dimethoxy - L - proline as a
colorless, viscous syrup, [a]25D -72" (c, 1% in EtOH).
The latter (3.4 g.) is triturated with 20 ml. of ethyl
acetate, rubbed, diluted with 30 ml. of hexane, and
cooled to give a colorless solid, weight 2.6 g., m.p.
108-110 , -770 (c,1% in EtOH).
Example 5
(S) - 1 - [3 - (Acetylthio) - 2 - methyl - 1- oxopropyl] - 4,4 - diethoxy - L - pro fine a) N - Carbobenzyloxy - 4,4 - diethoxy - L - proline, ethyl ester
Following the procedure of Example 3 (a) but sub
stituting triethyl orthoformate for the trimethyl
orthoformate and ethanol for the methanol one
obtains 10.8 g. of N - carbobenzyloxy - 4,4 - diethoxy
- L- proline, ethyl ester as a yellow oil.
b) N - Carbobenzyloxy -4,4- diethoxy - L - proline
The crude ester from part (a) (10.8 g., 0.03 mole) is
saponified with 70 ml. of 1 N sodium hydroxide
according to the procedure of Example 4(b), 30 ml.
of ethanol is added in 10 ml. portions to obtain a
solution, to give 10.5 g. of a yellow viscous oil. This
oil is dissolved in 100 ml. of ether and treated with
cyclohexylamine (3.0 g.). On seeding and rubbing,
8.3 g. of the crystalline N - carbobenzyloxy - 4,4
diethoxy - L- proline cyclohexylamine salt sepa
rates; m.p. 123-126" (s.114 ) [a!]26D -32 (c,1% in
ethanol). This material is recrystallized from 20 ml. of
acetonitrile to give 7.0 g. of the salt as a colorless solid; m.p. 125-128 (s. 115 ) [α]n -31 (c, 1% in ethanol).
The N - carbobenzyloxy - 4,4 - diethoxy - L - proline
cyclohexylamine salt is suspended in 40 ml. of ethyl
acetate, stirred and treated with 20 ml. of 1 N hydi rochloric acid. The layers are separated and the
aqueous phase is extracted with additional ethyl ace
tate (3 x 40 ml.), the organic layers are combined,
dried (MgSO4), and the solvent evaporated to give
5.6 g. (56%) of N - carbobenzyloxy - 4,4 - diethoxy - L
proline as a light yellow oil.
c) 4,4 - Diethoxy - L - proline
A solution of the N - carbobenzyloxy - 4,4 - dieth
oxy - L - proline (5.6 g., 0.017 mole) in 180 ml. of 2:1
ethanol-water is treated with 2 g. of a 5% palladium i carbon catalyst and shaken under 3 atmospheres of
hydrogen for six hours. The crude partly solid pro
duct is rubbed first under ethanol, then ether, and
the evaporation repeated each time to give 3 g. (91%)
of nearly colorless solid 4,4 - diethoxy - L - proline; m.p. 172-174" (dec.); preceded by gradual darkening
and sintering [a]2s -40 (c,1% in methanol).
Anal. Calc'd. for CgH17N04: 0.25 H2O: C, 52.03; H, 8.49; N, 6.74
Found: C, 52.22; H, 8.59; N, 6.69.
d) (S) - 1- [3 - (acetylthio) - 2 - methyl - 1- oxopropyl] - 4,4 - diethoxy - L - proline
The 4,4 - diethoxy - L - proline (2.9 g., 0.014 mole)
from part (c) and 3 g. (0.017 mole) of D - 3 - acetylthio
- 2 - methylpropionyl chloride dissolved in 3.5 ml. of
ether are reacted in 35 ml. of water in the presence of
sodium carbonate according to the procedure of
Example 3 (d) to yield 5.4 g. of pale yellow viscous
oil.This oily product is treated in 40 ml. of ethyl
acetate with 2.6 g. of dicyclohexylamine and diluted
with 60 ml. of hexane to yield in two crops 4.9 g. of (S) - 1 - [(3- acetylthio) - 2 - methyl - 1 - oxopropyl]
4,4- diethoxy - L- proline dicyclohexylamine salt;
m.p. 135-138 (s. 132'). Following recrystallization
from 15 ml. of hot ethyl acetate - 45 ml. of hexane,
the colorless solid salt weighs 4.2 g.; m.p. 138-140 (s. 135 ), [α]25D -63 (c, 1% in ethanol).
Anal. Calc'd. for CrsH2sN06S C12H2aN: C, 61.33; H, 9.15; N, 5.30; S, 6.06
Found: C, 61.48; H, 9.55; N, 5.25; S, 5.91.
The dicyclohexylamine salt is converted to the free
acid by suspending 4.2 g. in 40 ml. of ethyl acetate,
cooling and treating with 40 ml. of 10% potassium
bisulfate solution to give two layers. After separat
ing, the aqueous phase is extracted with ethyl ace
tate (3 x 50 ml.), the combined organic layers are
dried (MgSO4), and the solvent evaporated to give
3.0 g. (61%) of (S) - 1 - [3 - (acetylthio) - 2 - methyl - 1
oxopropyl] - 4,4 - diethoxy - L - proline as a pale
yellow viscous syrup.
Example 6 (S)-4,4-Diethoxy- 1- (3 - Mercapto - 2 - methyl- 1
oxopropyl) - L - proline Argon is passed through a cold solution of 5.5 ml.
of concentrated ammonium hydroxide in 13 ml. of water for 0.25 hour. The latter is then added while cooling under a blanket of argon to 3.0 g. (0.0086 mole) of (S) - 1 - [3 - (acetylthio) - 2 - methyl - 1 oxopropyl] - 4,4 - diethoxy - L - proline and the mixture is worked up as described in Example 4 to yield 2.4 g. (92%) of (S) - 4,4 - diethoxy - 1 - (3 - mercapto 2 - methyl - 1 - oxopropyl) - L - proline as a nearly colorless viscous syrup [a]26n -64 , (c, 1% in ethanol).
Anal. Calc'd. for C13H23NOs 0.25 H2O; C, 50.38; H, 7.64; N, 4.52; S, 10.35 Found: C, 50.68; H, 7.96; N, 4.78; S, 10.07.
Example 7 [2 (5), 3S] - 2 - [3 - RAcetylthio) - 2 - methyl - 1- oxopropyl] - 6, 10 - dioxo - 2 - azaspiro[4.5]decane - 3 - carboxylic acid a) N - Carbobenzyloxy -4,4- trimethylenedioxy - L proline
Interaction of 8.2 g. (0.031 mole) of N - carbobenzyloxy - 4 - keto - L - proline and 45 ml. (0.62 mole) of
1,3 - propanediol in 450 ml. of benzene in the presence of 500 mg. of p - toluenesulfonic acid gives 12.3 g. of crude viscous ester product. This product is saponified with 70 ml. of 1 N sodium hydroxide to give 10.6 g. of crude N - carbobenzyloxy - 4,4 trimethylenedioxy - L- proline as a yellow oil.The
latter is dissolved in 40 ml. of ethanol - 400 ml. ether
and treated with 3.2 g. of cyclohexylamine to yield
10.1 g. of N - carbobenzyloxy-4,4- trimethylenedioxy - L - proline, cyclohexylamine salt; m.p. 163-165'(s. 160 ). [α]25D-27 (c, 1% in ethanol). Crystallization of 9.8 g. of the salt from 300
ml. of acetonitrile yields 9.5 g. of colorless solid cyc
lohexylamine salt; m.p. 165-167 (s, 162") [a]25D -27 (c,1% in ethanol).
The cyclohexylamine salt (9.0 g.) is suspended in
40 ml. of ethyl acetate, stirred, cooled, and treated
with 45 ml. of 1 N hydrochloric acid. The layers are
separated, the aqueous phase extracted with addi
tional ethyl acetate (3 x 40 ml.), the combined
organic layers are dried (MgSO4), and the solvent
evaporated to give 7.1 g. (75%) of glass-like N - car
bobenzyloxy - 4,4 - trimethylenedioxy - L - proline.
b) 4,4- Trimethylenedioxy - L - proline
A solution of 7.1 g. (0.022 mole) of N - carbobenzyloxy - 4,4 - trimethylenedioxy - L - proline in 200
ml. of 2:1 methanol-water is hydrogenated in the
presence of 2 g. of 5% palladium- carbon catalyst to give 3.8 g. (93%) of nearly colorless 4,4 trimethylenedioxy - L - proline; m.p. 234-236 (dec.);
preceded by gradual darkening and sintering; [aJ25n -36 (c, 0.5% in 1:1 methanol-water).
Anal. Calc'd. for C8H13NO4: C, 51.33; H, 7.00; N, 7.48 Found: C, 51.42; H, 7.11; N, 7.40.
c)[2 (S), 3S] - 2 - [3 - fAcetylthio) - 2 - methyl - 1 oxopropyl] - 6, 10 - dioxo - 2 - azaspiro[4.5]decane - 3 - carboxylic acid
4,4 - Trimethylenedioxy - L - proline (3.7 g., 0.02 mole) is acylated with 4.0 g. (0.022 mole) of D - 3
acetylthio - 2 - methylpropionyl chloride in 50 ml. of water in the presence of sodium carbonate according to the procedure of Example 1 (e) to give 7.3 g. of glass-like crude product.
The product is converted to its dicyclohexylamine salt with 3.6 g. of dicyclohexylamine in 70 ml. of ethyl acetate. On seeding and rubbing, the crystalline salt precipitates to yield 7.5 g. of dicyclohex ylamine salt; m.p. 168-170' (s. 166'), [a] -59' (c, 1% in ethanol). Recrystallization from 30 ml. of acetonitrile gives 6.5 g. of colorless solid salt; m.p.
169-171 ,[a]25D -63 , (c, 1% in ethanol).
The dicyclohexylamine salt is converted to the free acid by suspending 6.4 g. in 75 ml. of ethyl acetate and treating with 75 ml. of 10% potassium bisulfate and stirring until two layers are obtained. After separating, the aqueous phase is extracted with ethyl acetate (4 x 75 ml.) the organic layers are combined, dried (MgSO4), and the solvent evaporated to give 4.3 g. (67%) of glass-like [2 (S), 3 - 2 - [3 (acetylthio) -2 - methyl - 1 - oxopropyl 6,1 - dioxo - 2 - azaspiro[4,5]decane - 3 - carboxylic acid.
Example 8 [2 (Sl 3S]-2-/3- Mercapto - 2 - methyl - 1 - oxop- ropyl) -6,10 - dioxo - 2- azaspiro[4,5]decane - 3 - carboxylic acid
[2 (S), 3S] - 2 - [3 - (Acetylthio) - 2 - methyl - 1 oxopropyl] - 6,10 - dioxo - 2 - azaspiro[4,5]decane - 3 - carboxylic acid (4.3 g., 0.013 mole) is hydrolyzed with 8.5 ml. of concentrated ammonia in 20 ml.
according to the procedure of Example 2 to yield 0.9 g. of colorless solid product; [aj25D -64 (c,0.5% in ethanol). An additional 0.8 g. of product is obtained
by extracting the aqueous phase with chloroform; [a]250 -66 . The two crops are dissolved in chloroform, evaporated, rubbed under ether, and the evaporating repeated to yield 1.7 g. (46%) of[2 (S), 3S] - 2 - (3 - mercapto - 2 - methyl - 1 - oxopropyl) 6,10 - dioxo - 2 - azaspiro[4,5]decane - 3 - carboxylic acid; m.p. 169-171" (s. 167 ),[α]26D -71 (e 1% in methanol).
Anal. Calc'd. for C12H19NOsS: C, 49.81; H, 6.62; N, 4.84; S,11.08
Found: C, 49.67; H, 6.67; N, 4.93; S, 11.10.
Example 9 [7(S), 8S] - 7- [3- (Acetylthio)-2-methyl- 1 oxopropyl] - 7 - aza - 1,4- dithiaspiro[4.4]nonane -8carboxylic acid a) N - Carbobenzyloxy -4,4- ethylenedithio - L - proline, methylester
A stirred solution of 3.9 g. (0.014 mole) of N - carbobenzyloxy - 4 - keto - L - proline, methyl ester in 60 ml. of methylene chloride is treated with 3 ml. (0.036 mole) of ethanedithiol, cooled to 8 , and treated under an argon blanket with 3 ml. (0.024 mole) of boron trifluoride etherate. After removing the cooling bath, the pale yellow solution is stirred for an additional hour and kept overnight at room temperature. The solution is stirred, treated with several pieces of crushed ice, followed by 20 ml. of water.
After 30 minutes the layers are separated and the aqueous phase (50 ml.) is extracted with additional methylene chloride (3 x 30 ml.). The combined organic layers are washed with 50 ml. of satu rated sodium chloride solution, dried (MgSO4), and the solvent removed on a rotary evaporator to give 6 g.
(100%) of a pale yellow oil N - carbobenzyloxy - 4,4 ethylenedithio - L - proline, methyl ester.
b) N - Carbobenzyloxy - 4,4 - ethylenedithio - L - proline
The methyl ester product from part (a) (7.4 g., approximately 0.018 mole) is dissolved in 65 ml. of methanol, treated dropwise at - 1 to 4" with 14.5 ml.
(0.029 mole) of 2N sodium hydroxide, kept at 0" for one hour, and at room temperature overnight. After removing about half the solvent on a rotary evaporator, the solution is diluted with 125 ml. of water, washed with ether (wash discarded), acidified while cooling with 5 ml. of 1:1 hydrochloric acid to a pH of 2, and extracted with ethyl acetate (4 x 50 ml.).
The combined extracts are washed with 50 ml. of saturated sodium chloride, dried (MgSO4), and the solvent evaporated to give 6 g. of a pale yellow viscous oil. This oil is dissolved in 25 ml. of ethanol, treated with 1.8 g. of cyclohexylamine in 5 ml. of ethanol, and diluted to 300 ml. with ether. On seeding and rubbing, the crystalline cyclohexylamine salt separates to yield after overnight cooling 5.7 g. of N carbobenzyloxy - 4,4 - ethylenedithio - L - proline cyclohexylamine salt; m.p. 205-207" (s. 201'). Recrystallization from 50 ml. of ethanol - 400 ml. ether yields 4.9 g. of colorless solid salt; m.p. 207-209" (s.
2OlO),[a]2C -15' (c, 1% in chloroform).
The cyclohexylamine salt (4.8 g.) is suspended in 25 ml. of ethyl acetate, stirred, and treated with 25 ml. of 1 N hydrochloric acid. When two clear layers are obtained, they are separated, the aqueous phase is extracted with additional ethyl acetate (3 x 25 ml.), the combined organic layers are dried (MgSO4), and the solvent evaporated to give 3.8 g. (62%) of N carbobenzyloxy - 4,4 - ethylenedithio - L - proline as a pale yellow viscous syrup.
c) 4,4- Ethylenedithio - L - proline, hydrobromide N - Carbobenzyloxy - 4,4 - ethylenedithio - L - proline (3.7 g., 0.011 mole) is treated with 20 ml. of hydrogen bromide in acetic acid (30-32%), stoppered loosely, and stirred magnetically. Mixing is difficult due to the viscosity of the starting material and the latter is broken up as much as possible with a spatula. In the meantime, the crystalline product begins to separate. Further quantities of hydrogen bromide in acetic acid are added after 15 minutes (10 ml.) and after 25 minutes (5 ml.) and stirring is continued for a total of 35 minutes.Ether (250 ml.) is added to complete precipitation of the product and after cooling for 15 minutes the cream coloured material is filtered under nitrogen, washed with ether, and dried in vacuo to give 2.7 g. of 4,4 ethylenedithio - L - proline, hydrobromide; m.p.
240-242" (dec.); sintering and darkening from approximately 200 ; [a]26D40 (c, 0.5% in 1:1 chloroform- methanol).
d) [7 (5), 8S] - 7- [3 (Acetylthio)-2-methyl- 1 - oxopropyl] - 7 - aza - 1,4- dithiaspiro[4.4]nonane - 8- carboxylic acid
A stirred solution of 2.6 g. (0.0091 mole) of 4,4 ethylenedithio - L - proline, hydrobromide in 25 ml.
of water is cooled to 59 and brought to pH 8.2 by the addition of 25% sodium carbonate (wt./vol.). While continuing stirring and cooling, a solution of 1.9 g.
(0.01 mole) of D - 3 - acetylthio - 2 - methylpropionyl chloride in 2.5 ml. of ether is added portionwise while maintaining the pH at 7.5-8.2 by the dropwise addition of 25% sodium carbonate. When the pH is stabilized at 8.2-8.5 (after about 15 minutes), stirring and cooling are continued for a total of one hour.
The solution is then washed with 25 ml. of ethyl acetate (wash discarded), layered over with 25 ml. of ethyl acetate, cooled, stirred, acidified carefully with 1:1 hydrochloric acid to pH 2.0, saturated with sodium chloride, and the layers separated. The aqueous phase is extracted with additional ethyl acetate (3 x 25 ml.), the combined organic layers dried (MgSO4), and the solvent evaporated, finally at 0.2 mm., to give 2.6 g. of syrupy product which begins to crystallize. The latter is treated in 30 ml. of ethyl acetate with 1.5 g. of dicyclohexylamine to give 3.0 g. of colorless dicyclohexylamine salt; m.p. 176-178" (s, 170 ); [a]26D -55 (c,1% in ethanol). This material is ground in a mortar under 15 ml. of acetonitrile, cooled for one hour, filtered, washed with 5 ml. of cold acetonitrile and with ether, and dried to give 2.9 g. of dicyclohexylamine salt; m.p. 177-179" (s, 172"); [a]2e,a -56' (c,1% in ethanol).
Anal. Calc'd. for Cr3HrgNO4S C,2Ha3N: C, 56.56; H, 7.98; N, 5.28; S, 18.12 Found: C, 56.21; H, 8.18; N, 5.05; S, 18.00.
The above dicyclohexylamine salt is converted to the free acid by suspending 2.8 g. in 30 ml. of ethyl acetate, cooling, and treating with 30 ml. of 10%
potassium bisulfate to give two clear layers. After separating, the aqueous phase is extracted with ethyl acetate (3 x 30 ml.), the combined organic layers dried (MgSO4), and the solvent evaporated, finally at 0.1-0.2 mm and 45 , to give 2.0 g. (63%) of colorless solid [7 (S),8S]-7- [3 - (acetylthio) - 2 - methyl - 1 - oxopropyl] -7 - aza - 1,4- dithiaspiro[4.4] - nonane - 8 - carboxylic acid, m.p., 125-126 (s,122 ); [o]2D -101 (c,1% in ethanol).
Example 10 [7 {S), 8S] - 7 - {3 - Mercapto - 2 - methyl - 1- oxop- ropyl) -7 - aza - 1,4 - dithiaspiro[4.4]nonane -8carboxylic acid
Argon is passed through a cold solution of 3.5 ml.
of concentrated ammonia in 8.5 ml. of water for 15 minutes. The latter is then added while cooling and under a blanket of argon to 1.9 g. (0.0054 mole) of [7 (S),8S] - 7 - [3 - (acetylthio) - 2 - methyl - 1 - oxop- ropyl] - 7 - aza - 1,4 - dithiaspiro[4.4] nonane - 8 - carboxylic acid and the mixture is swirled in an icebath until a solution is obtained. Stirring under argon is continued at room temperature for an additional two hours, then the solution is extracted with 15 ml. of ethyl acetate under an argon atmosphere.
The aqueous layer is cooled, stirred, layered over with 15 ml. of ethyl acetate, and acidified portionwise with approximately 6.5 ml. of 1:1 hydrochloric acid. The layers are separated, the aqueous phase extracted with additional ethyl acetate (3 x 15 ml.) the combined acetate layers dried (MgSO4), and the
solvent evaporated to give a glass-like residue which
solidifies when rubbed under ether. The evaporation
is repeated and the colorless product is suspended
in 30 ml. of hexane, filtered and dried in vacuo to give 1.4 Ag. (84%) of[7 (S), 8S] - 7 - (3 - mercapto - 2 - methyl - 1 - oxopropyl) - 7 - aza - 1,4 - dithias
piro[4.4]nonane - 8 - carboxylic acid; m.p. 116-118 (s, 105'); [α]25D -44 (c, 1% in ethanol).
Anal. Calc'd. forC11H17NO3S3:
C, 42.97; H, 5.57; N, 4.56; S, 31.29; SH,100%
Found: C, 42.70; H, 5.71; N, 4.54; S, 31.16; SH, 100%.
Example 11 [7 as] - 7 - (3 - Mercapto -2-methyl- 1 - oxop- ropyl) - 1,4 - dioxo - 7 - azaspiro[4.5]decane - 8 carboxylic acid a)[7 (5), 85] - 7-[3 - (Acetylthio)-2-methyl- 1 oxopropyl] - 1,4- dioxo - 7 - azaspiro[4.5]decane -8carboxylic acid
Following the procedure of Example 1 but sub
stituting an equivalent amount of N - carboben
zyloxy - 5 - keto - L - pipecolic acid for the N - car
bobenzyloxy - 4 - keto - L - proline in part (c) and then
following the procedure of parts (d) and (e) one
obtains, [7 (S), 8S] - 7 - [3 - (acetylthio) - 2 - methyl - 1
- oxopropyl] - 1,4 - dioxo - 7 - azaspiro[4.5] decane - 8 - carboxylic acid.
b)[7(S), as] - 7- (3-Mercapto -2-methyl- 1 - oxopropyl) - 1,4 - dioxo - 7 - azaspiro[4.5]decane - 8
carboxylic acid
The product from part (a) is hydrolyzed with con
centrated ammonia according to the procedure of
Example 2 to yield [7 (S), 8S] - 7 - (3 - mercapto - 2
methyl - 1 - oxopropyl) - 1,4 - dioxo - 7- azas- piro[4.5]decane - 8 - carboxylic acid.
Example 12 [1 (5), 2S]-1-(3-Mercapto-2-methyl-1-oxop- ropyl) -5,5 - dimethoxy - 2 - piperidinecarboxylic acid a1[7 fSJ, 2S] - 7-[3-(Acetylthio-2- methyl- I- oxopropyl] - 5,5 - dimethoxy - 2 - piperidinecarboxylic acid
Following the procedure of Example 3 but substituting an equivalent amount of N - carbobenzyloxy - 5 - keto - L - pipecolic acid for the N - carbobenzyloxy - 4- keto - L - proline in part (a) one obtains[1 (S), 2S] - 1 -[3-(acetylthio)-2-methyl-1oxopropyl] - 5,5 - dimethoxy -2 - piperidinecarboxylic acid.
b)[1(S),2S]-1-(3-Mercapo-2- methyl-1- oxopropyl) -5,5- dimethoxy -2- piperidinecarboxylic acid
The product from part (a) is hydrolyzed with concentrated ammonia according to the procedure of Example 4 to yield [1(S), 2S] - 1 - (3 - mercapto - 2 - methyl - 1 - oxopropyl) - 5,5 - dimethoxy -2- piperidinecarboxylic acid.
Example 13 [1 (S), 2]-1-(3- Mercapto -2-methyl-l- oxop- ropyl) -4,4- dimethoxy - 2 - piperidinecarboxylic acid a)[1(S),2]-1-[3-(Acetylthio)-2-methyl-1- oxopropyl]-4,4- dimethoxy - 2 piperidinecarbox- ylic acid
Following the procedure of Example 3 but substituting an equivalent amount of N - carbobenzyloxy - 4 - keto - 2 - pipecolic acid for the N - car bobenzyloxy - 4 - keto - L - proline in part (a) one obtains[1 (S), 2t] - 1 - [3 - (acetylthio) - 2 - methyl - 1 - oxopropyl] - 4,4 - diethoxy - 2 - piperidinecarboxylic
acid.
b)[1(s),2-1-[3-Mercapto-2-methyl-1- oxopropyl) -4,4- dimethoxy - 2- piperidinecarbox- ylic acid
The produce from part (a) is hydrolyzed with concentrated ammonia according to the procedure of
Example 4 to yield [1(S), 2] - 1 - (3 - mercapto - 2 methyl - 1 - oxopropyl) - 4,4 - dimethoxy - 2piperidinecarboxylic acid.
Example 14 [2 3S] -2- (3-Mercapto -2-methyl- 1 - oxop- ropyl) - 6,10 - dithia -2 - azaspiro[4.5]decane - 3 carboxylic acid a) [2 (S), 3S] - 2 - [3 - (Acetylthio) - 2 - methyl - 1- oxopropyl) - 6,10 - dithia -2-azaspiro[4.5]decane-3 - carboxylic acid
Following the procedure of Example 9 but substituting 1,3 - propanedithiol for the ethanedithiol in
part (a), one obtains [2 (S),3S] - 2 - [3 - (acetylthio) - 2 - methyl - 1 - oxopropyl] - 6,10 - dithio - 2 - azas
piro[4.5]decane - 3 - carboxylic acid.
b)[2(S),3S]-2-(3-Mercapto-2-methyl- 1oxopropyl) -6,10 - dithia - 2 - azaspiro[4.5]decane - 3 - carboxylic acid
The product from part (a) is hydrolyzed with con
centrated ammonia according to the procedure of
Example 10 to yield [2 (S) 3S] - 2 - (3 - mercapto - 2
methyl - 1 - oxopropyl) - 6,10 - dithia - 2 azas
piro[4.5]decane - 3 - carboxylic acid.
Example 15 [7(S), as] - 7- 63 - Mercapto -2-methyl- 1 - oxop- ropyl) - 1 - oxo - 4 - thia - 7 - azaspiro[4.4]nonane - 8
carboxylic acid a)[7 (S), 8S]-7-[3- (Acetylthio)-2-methyl- 1 - oxopropyl] - 1- oxo - 4 - thia - 7 - azaspiro[4.4]nonane - 8 - carboxylic acid
Following the procedure of Example 1 but substituting 2 - metcaptoethanol for the ethylene glycol in part (c), one obtains [7 (S), 8S] - 7 - [3 - (acetylthio) -2-methyl-1- oxopropyl]-l- oxo-4-thia-7- azaspiro[4.4] nonane - 8 - carboxylic acid.
6/ [7 (SJ, BS]-7-(3-Mercapto-2 -methyl-l- oxopropyl) - 1- oxo - 4 - thia - 7 - azaspiro[4.4]nonane - 8 - carboxylic acid
The product from part (a) is hydrolyzed with concentrated ammonia according to the procedure of
Example 2 to yield [7 (S), 8S] - 7 - (3 - mercapto - 2 methyl - 1 - oxopropyl) - 1 -oxo-4-thia-7-azas- piro[4.4] nonane - 8 - carboxylic acid.
Example 16 (85) -7 - [3 - (Acetylthio) - 2- trifluoromethyl - 1 oxopropyl] - 1,4- dioxo - 7- azaspiro[4.4]nonane -8- carboxylic acid
Isomers A and B a) D,L -3- (Acetylthio) -2- trifluoromethylpropionic acid a- Trifluoromethyl acrylic acid (10 g., 0.071 mole) [prepared according to the procedure set forth J.
Chem. Soc., 1954, p.371] is cooled in a salt-ice-water bath, stirred and treated portionwise with 5.7 ml.
(0.075 mole) of 97% thiolacetic acid. After the addition, the yellow liquid is stirred in the cold for one hour, allowed to warm to room temperature, and distilled to yield 14 g. (91%) of D,L - 3 - (acetylthio) - 2 - trifluoromethylpropionic acid as a light yellow oil, b.p. 149-153'/13 mm. The material solidifies on storing in the cold.
b) D,L - 3- (Acetylthio) -2- trifluoromethylpropionyl chloride
The D,L - 3 - (acetylthio) - 2 - trifluoromethylpropionyl acid (7 g., 0.032 mole) is treated with 18 ml. (0.25) of redistilled thionyl chloride and the mixture is refluxed for three hours. After removing the excess thionyl chloride on a rotary evaporator, the residue is distilled to give 6.8 g. of D,L - 3 - (acetylthio) - 2 - trifluoromethylpropionyl chloride as a pale yellow oil; b.p. 80-82']16 mm.
c) (85) -7- [3- (Acetylthie) - 2- trifluoromethyl - 1 oxopropyl] - 1,4- dioxo - 7 - azaspiro[4.4]nonane -8carboxylic acid (Isomers A and B)
4,4 - Ethylenedioxy - L - proline (2.4 g., 0.014 mole) is reacted with 3.4 g. (0.014 mole) of D.L - 3 - (acetylthio) - 2 - trifluoromethylpropionyl chloride in 40 ml.
of water in the presence of sodium carbonate according to the procedure of Example 1 (e) to yield 4.5 g. of nearly colorless solid product; m.p. 126-145' (s.115 ),[α]25D -34 (c,1% in ethanol).
The mixture of diastereoisomers (4.2 g.) is suspended in 45 ml. of ether, stirred for two hours, cooled for 20 minutes, and the undissolved solid is filtered, washed with cold ether, and air dried to yield 2.7 g. of product; m.p. 166-172 (s.140 ),[a]25D -62 (c, 1% in ethanol). The material is then ground in a motar under 25 ml. of ether, filtered after 15 minutes, washed with some ether, and again airdried to yield 2.1 g. of product; m.p.172-177 (s.
143 ). Following crystallization from 11 ml. of boiling isopropanol and cooling overnight, 1.55 g. of colorless (8S) - 7 - [3 - (acetylthio - 2 - trifluoromethyl - 1 oxopropyl] - 1,4 - dioxo - 7 - azaspiro[4.4] nonane - 8- carboxylic acid, isomer A is obtained; m.p. 192-194 (s,183 ), [a]25D -32 (c, 1% in.ethanol). A sample is recrystallized from isopropanol; m.p. 193-195 (s, 184 ), [α]25D -134 (c,1% in ethanol).
Isomer B is obtained by combining the above ether and isopropanol filtrates and removing the solvents under reduced pressure to give 2.2 g. of a pale yellow solid; m.p. 108-109 (s, 95 ); [a]25D +30 (c, 1% in ethanol). This material is purified by crystallization from 6 ml. of isopropanol to give 1.2 g. of nearly colorless solid; m.p. 153-155 (s,130 ), [α]25D +40 (c, 1% in ethanol).After crystallization from 4 ml. of ethyl acetate -6 ml. of hexane, 1.1 g. of (8S) - 7 -[3 - (acetylthio) - 2 - trifluoromethyl - 1 - oxopropyl]- 1,4 - dioxo - 7 - azaspiro[4.4]nonane - 8 - carboxylic acid, isomer B; m.p. 153-155' (s,141'), [a]25o +41' (c, 1% in ethanol) is obtained.
Example 17 (8S) - 7 - (3- Mercapto - 2 - trifluoromethyl-1- oxopropyl) - 1,4- dioxo - 7- azaspiro[4.4]nonane - 8 carboxylic acid, Isomer A
Isomer product from Example 16(1.45 g., 0.0039 mole) is hydrolyzed with 2.5 ml. of concentrated ammonia in 6 ml. of water over a period of one hour as described in Example 2 to yield 1.25 g. (97%) of colorless (8S) - 7 - (3 - mercapto - 2 - trifluoromethyl 1 - oxopropyl) - 1,4 - dioxo - 7 - azaspiro [4.4] nonane 8 - carboxylic acid, isomer A, as a glass-like product, [a]25D -61 (c,1% in ethanol). TLC:Rf 0.40 (95:5:5 methylene chloride -methanol - acetic acid; vis. SH reagent, PMA and heat).
Anal. Calc'd. forC11H14F3NOsS: C, 40.12; H, 4.28; N, 4.25; S, 9.74; F, 17.31 Found: C, 40.10; H,4.43; N, 4.51; S, 9.63; F, 17.10.
The above acid is dissolved in ethyl acetate and treated with 1 - adamantanamine to yield the 1 adamantanamine salt; m.p.213-215 (dec.),[α]25D -47" (c, 1% in methanol).
Example 18 (85) -7 - (2- Mercapto - 2 - trifluoromethyl - 1oxopropyl) - 1,4 - dioxo -7 - azaspiro[4.4]nonane - 8 carboxylic acid, Isomer B
Isomer B produce from Example 16 (1.05 g., 0.0028 mole) is hydrolyzed with 2 ml. of concentrated ammonia in 5 ml. of water according to the procedure described in Example 2 to yield 0.9 g. (97%) of (8S) - 7 - (3 - mercapto - 2 - trifluoromethyl - 1 oxopropyl) - 1,4 - dioxo - 7 - azaspiro[4.4]nonane - 8 carboxylic acid, Isomer B as a pale yellow viscous syrup; [a]25D -16 (c,1% in ethanol). The material sets to a waxy solid; m.p. 61-64 (s.55 )
Anal. Calc'd. for: C11H14F3NOsS 0.25 H2O: C, 39.58; H, 4.38; N, 4.20; S, 9.61; F, 17.01 Found: C, 39.60; H, 4.28; N, 4.26; S, 9.62; F, 16.89.
Example 19 1- [3 - (Acetylthio) - 2 - trffluoromethyl - 1- oxopropyl] - 4,4 - dimethoxy - L -profine, Isomers A and B
Following the procedure of Example 16 but substituting 4,4 - dimethoxy - L - proline for the 4,4 ethylenedioxy - L - proline in part (c), one obtains 1 [3 - (acetylthio) - 2 - trifluoromethyl - 1 - oxopropyl] 4,4 - dimethoxy - L - proline as a racemic mixture.
The individual isoners can be separated as taught in
Example 16.
Example 20 1- (3 - Mercapto - 2 - trifluoromethyl - 1- oxopropyl) - 4,4 - dimethoxy - L - proline, IsomerA and lsomerB
Each individual isomerproductfrom Example 19 is hydrolyzed with concentrated ammonia according to the procedure of Example 4 to yield 1 - (3 - mer capto - 2 - trifluoromethyl - 1 - oxopropyl) - 4,4 dimethoxy - L - proline, isomer A and 1 - (3 - mer capto - 2 - trifluoromethyl - 1 - oxopropyl) - 4,4 dimethoxy - L - proline, isomer B.
Example 21 [7(5), 85] -7 - (3 - Mercapto - 2- mercaptomethyl - 1 - oxopropyl) - 1,4 - dioxo - 7 - azaspiro[4.4]nonane -8carboxylic acid a) [7(5), 85] -7 - [3- (Acetylthio) - 2- (acetylthiomethyl) - 1- oxopropyl] - 1,4- dioxo - 7 - azaspiro[4.4]nonane - 8 - carboxylic acid
Following the procedure of Example 1 but substituting D -2- acetylthiomethyl - 3 - acetylthiopropionyl chloride for the D - 3 - acetylthio - 2 methylpropionyl chloride in part (3), one obtains [7(S), 8S] - 7 - [3 - (acetylthio) - 2 - (acetylthiomethyl) 1 - oxopropyl]- 1,4- dioxo - 7 - azaspiro[4.4]nonane 8 - carboxylic acid.
b) [7(5), 8S] - 7 - 63 - Mercapto - 2 - mercaptomethyl 1- oxopropyl) - 1,4 - dioxo -7- azaspiro[4.4]nonane 8 - carboxylic acid
The product from part (a) is hydrolyzed with concentrated ammonia according to the procedure of
Example 2 to yield [7 (S). 8S] - 7 - (3 - mercapto - 2 mercaptomethyl - 1 - oxopropyl) -1,4 - dioxo - 7 - azaspiro[4.4]nonane - 8 - carboxylic acid.
Example 22 (5) - 1- (3 - Mercapto - 2 - mercaptomethyl - 1- oxopropyl) - 4,4 - dimethoxy - L - proline a) (S)- - 1- 3 - (Acetylthio) -2 - (acetylthiomethyl) - 1- oxopropyl - 4,4 - dimethoxy - L - proline
Following the procedure of Example 3 but substituting D - 2 - acetylthiomethyl -3- acetylthiopropionyl chloride for the D - 3 - acetylthio - 2 methylpropionyl chloride in part (d), one obtains (S) - 1 - [3 - (acetylthio) - 2 - (acetylthiomethyl) - 1 oxopropyl] - 4,4 - dimethoxy - L - proline.
b) (S)- 1 (3 - (3-Mercapto -2 - mercaptomethyl - 1- oxopropyl) - 4,4- dimethoxy - L - proline
The product from part (a) is hydrolyzed with concentrated ammonia according to the procedure of
Example 4 to yield (S) - 1 - (3 - mercapto - 2 - mercaptomethyl - 1 - oxopropyl) - 4,4 - dimethoxy - L - proline.
Example 23 (8S) -7 - (3- Mercapto - 2- methylthio - 1- oxopropyl) - 1,4- dioxo - 7- azaspiro[4.4]nonane -8-carboxylic acid a)3 - (Acetylthio) -2 - {methylthio) propionic acid
12.5 g. (0.094 mole) of methyl - 2 - (methylthio) [prepared from methyl 2 - chloroacrylate according to the procedure of Gundesmann et al., Chemische Berichte 94,3254(1916)] is stirred with 1N aqueous
sodium hydroxide (94 ml.) with ice cooling. The mix
ture is allowed to warm to ambient temperature, then stirred for five hours. The resulting solution is
washed with ether, then acidified to pH 2 with con
centrated hydrochloric acid.The solid precipitate is extracted into methylene chloride, and the solution
is washed with saturated sodium chloride and the solvent evaporated. The solid residue, 2 - (methylthio) acrylic acid; m.p. 70-75 , is used immediately in the following reaction.
Equimolar amounts of 2 - (methylthio) acrylic acid and thioacetic acid are mixed under argon and stirred at 80 for several hours to yield 3 - (acetylthio) - 2 - (methylthio) propionic acid.
b) 3 - tAcetylthio) - 2 - (methylthie) propionic acid chloride
The 3 - (acetylthio) - 2 - (methylthio) propionic acid is refluxed inthionyl chloride for two hours. The reaction mixture is distilled to remove excess thionyl chloride and the product is distilled in vacuo to yield 3 - (acetylthio) - 2 - (methylthio) propionic acid chloride.
c) (85) - 7 - [3- (Acetylthie) - 2- methylthio - 1 - oxopropyl] - 1,4 - dioxo - 7 - azaspiro[4.4]nonane - 8 carboxylic acid
4,4 - Ethylenedioxy - L - proline is reacted with 3 (acetylthio) - 2 - (methylthio) propionic acid chloride according to the procedure of Example 1 (e) to yield (8S) - 7 - [3 - (acetylthio) - 2 - methylthio - 1 - oxopropyl] - 1,4 - dioxo - 7 - azaspiro[4.4]nonane - 8 carboxylic acid.
d) (8S) - 7 - {3 - Mercapto -2- methylthie - 1- oxopropyl) - 1,4- dioxo - 7 - azaspiro[4.4]nonane -8carboxylic acid
The product from part (c) is treated with concentrated ammonia according to the procedure of
Example 2 to yield (8S) -7- (3 - mercapto - 2 - methylthio - 1 - oxopropyl) - 1,4 - dioxo - 7 - azas- piro[4.4]nonane - 8 - carboxylic acid.
Example 24 1- 63 - Mercapto - 2- methylthio - 1 - oxopropyl) - 4,4 - dimethoxy - L - proline a) 1- [3- (Acetylthie) - 2- methylthio - 1- oxopropyl] 4,4- dimethoxy - L - proline
4,4 - Dimethoxy - L - proline is reacted with 3 (acetylthio) - 2 - (methylthio) propionic acid chloride according to the procedure of Example 3(d) to yield 1 - [3 - (acetylthio) - 2 - methylthio - 1 - oxopropyl] - 4,4 - dimethoxy - L - proline.
b) 1- (3- Mercapto - 2- methylthio - 1 - oxopropyl) - 4,4 - dimethoxy - L - proline
The product from part (a) is hydrolyzed with concentrated ammonia according to the procedure of
Example 4 to yield 1 - (3 - mercapto - 2 - methylthio 1 - oxopropyl) - 4,4 - dimethoxy - L - proline.
Example 25 (85) -7 - (3- Mercapto - 1 - oxopropyl) - 1,4 - dioxo -7 - azaspiro[4.4]nonane - 8 - carboxylic acid a) (8S) -7 - [3 - (Acetylthio) - 1- oxopropyl] - 1,4 dioxo - 7 - azaspiro[4.4]nonane - 8 - carboxylic acid
4,4 Ethylenedioxy - L - proline is reacted with 3 acetylthiopropionyl chloride according to the procedure of Example 1 (e) to yield (8S) - 7 - [3 - (acetyl thio)- 1 -oxopropyl] - 1,4-dioxo-7-azaspiro[4.4] nonane - 8 - carboxylic acid.
t) (8S) - 7- {3 - Mercapto - 1- oxopropyl)- 1,4- dioxo - 7 - azaspiro[4.4]nonane - 8 - carboxylic acid
The product from part (a) is hydrolyzed with concentrated ammonia according to the procedure of
Example 2 to yield (8S) - 7 - (3 - mercapto - 1 - oxop ropyl) - 1,4 - dioxo - 7 - azaspiro[4.4] nonane - 8 carboxylic acid.
Example 26 1- (3-Mercapto- 1-oxopropyl)-4,4-dimethoxy-L proline a) 1- [3 - (Acetylthie) - 1- oxopropyl] - 4,4 dimethoxy - L - proline 4,4 - Dimethoxy - L - proline is reacted with 3 acetylthiopropionyl chloride according to the procedure of Example 3 (d) to yield 1 - [3 - (acetylthio) - 1 oxopropyl] - 4,4 - dimethoxy - L - proline.
b) 1- (3 - Mercapto - 1- oxopropyl) - 4,4 - dimethoxy - L - proline
The product from part (a) is hydrolyzed with concentrated ammonia according to the procedure of
Example 4 to yield 1 - (3 - mercapto - 1 - oxopropyl) 4,4- dimethoxy - L - proline.
Example 27 (8S) -7 - (4 - Mercapto - 1- oxobutyl) - 1,4 - dioxo - 7 - azaspiro[4.4]nonane - 8 - carboxylic acid a) (8S) - 7 - [4 - (Acetylthio) - 1- oxobutyl] - 1,4 - dioxo - 7- azaspiro[4.4]nonane - 8 - carboxylic acid 4,4 - Ethylenedioxy- L - proline is reacted with 4acetylthiobutyroyl chloride according to the procedure of Example 1 (e) to yield 8 (S) - 7 - [4 - (acetylthio) - 1 - oxobutyl] - 1,4 - dioxo - 7 - azaspiro[4.4] nonane - 8 - carboxylic acid.
b) (8S) -7 - (4 - Mercapto - 1- oxobutyl) - 1,4 - dioxo 7 - azaspiro[4.4]nonane - 8 - carboxylic acid
The product from part (a) is hydrolyzed with concentrated ammonia according to the procedure of
Example 2 to yield (8S) - 7 - (4 - mercapto - 1 oxobutyl) - 1,4 - dioxo - 7 - azaspiro[4.4] nonane - 8 carboxylic acid.
Example 28
1 - (4-Mercapto - 1 -oxobutyl)-4,4-dimethoxy- L proline a) 1- [4 - (Acetylthio) - 1- oxobutyl] - 4,4 - dimethoxy - L - proline 4,4 - Dimethoxy - L - proline is reacted with 4 acetylthiobutyroyl chloride according to the procedure of Example 3 (d) to yield 1 - [4 - (acetylthio) - 1 oxobutyl] -4,4- dimethoxy - L - proline.
b) 1 - (4 - Mercapto - 1 - oxobutyl) - 4,4 - dimethoxy - L - proline
The product from part (a) is hydrolyzed with concentrated ammonia according to the procedure of
Example 4 to yield 1 - (4 - mercapto - 1 - oxobutyl) 4,4- dimethoxy - L - proline.
Example 29 (8S) - 7 - (2 - Mercapto - 1 -oxoethyl)- 1,4 - dioxo - 7 - azaspiro[4.4]nonane - 8 - carboxylic acid a) (85) -7 - [2 - (Acetylthio) - 1- oxoethyl] - 1,4 - dioxo - 7 - azaspiro[4.4]nonane - 8 - carboxylic acid
4,4 - Ethylenedioxy - L - proline is reacted with
acetylthioacetyl chloride according to the procedure
of Example 1 (e) to yield (8S)- 7 -[2 - (acetylthio) - 1
oxoethyl] - 1,4 - dioxo - 7- azaspiro[4.4] nonane - 8
carboxylic acid.
b) (8S) - 7 - (2 - Mercapto - 1- oxoethyl) - 1,4 - dioxo
7 - azaspiro[4.4]nonane - 8 - carboxylic acid
The product from part (a) is hydrolyzed and con
centrated ammonia according to the procedure of
Example 2 to yield (8S) - 7 - (2 - mercapto - 1
oxoethyl) - 1,4 - dioxo - 7 - azaspiro[4.4] nonane - 8 carboxylic acid.
Example 30 1- (2 - Mercapto - 1- oxoethyl) - 4,4 - dimethoxy - L - proline a) 1- [2- (Acetylthio) - 1 - oxoethyl] - 4,4 - dimethoxy
L - proline
4,4 - Dimethoxy - L- proline is reacted with acetylthioacetyl chloride according to the procedure of
Example 3 (d) to yield 1 - [2 - (acetylthio) - 1 oxoethyl] - 4,4 - dimethoxy - L - proline.
b) 1 (2 - Mercapto - 1- oxoethyl)-4,4-dimethoxy-L - proline
The product from part (a) is hydrolyzed with concentrated ammonia according to the procedure of
Example 4 to yield 1 - (2 - mercapto - 1 - oxoethyl) 4,4- dimethoxy - L - proline.
Example 31 (85) -7 - (3 - Mercapto - 2,2 - dimethyl - 1 - oxopropyl) - 1,4- dioxo - 7- azaspiro[4.4]nonane -8-carboxylic acid a) (8S) - 7 - [3 - (Acetylthio) - 2,2 - dimethyl - 1oxopropyl] - 1,4- dioxo -7- azaspiro[4.4]nonane -8carboxylic acid
4,4 - Ethylenedioxy - L - proline is reacted with 3 acetylthio - 2,2 - dimethylpropionyl chloride according to the procedure of Example 1 (e) to yield (8S) - 7 - [3 - (acetylthio) - 2,2 - dimethyl - 1 - oxopropyl] - 1,4 dioxo - 7 - azaspiro[4.4]nonane - 8 - carboxylic acid.
b) (8S) - 7- (3 - Mercapto - 2,2 - dimethyl - 1 - oxopropyl) - 1,4- dioxo - 7 - azaspiro[4.4]nonane -8carboxylic acid
The product from part (a) is hydrolyzed with concentrated ammonia to yield (8S) - 7 - (3 - mercapto 2,2 - dimethyl - 1 - oxopropyl) - 1,4- dioxo - 7 azaspiro[4.4]nonane - 8 - carboxylic acid.
Example 32
1 - (3 Mercapto - 2,2 - dimethyl - 1- oxopropyl) -4,4- dimethyoxy - L - proline al 1- [3 - (Acetylthio) - 2,2- dimethyl - 1- oxopropyl] 4,4- dimethoxy - L - proline
4,4 - Dimethoxy - L - proline is reacted with 3 acetylthio - 2,2 - dimethylpropionyl chloride accord
ing to the procedure of Example 3 (d) to give 1 - [3
(acetylthio) -2,2 - dimethyl - 1 - oxopropyl] - 4,4 dimethoxy- L- proline.
b) 1 - (3 - Mercapto -2,2 - dimethyl - 1- oxopropyl) 4,4 - dimethoxy - L - proline The product from part (a) is hydrolyzed with concentrated ammonia according to the procedure of
Example 4 to give 1 - (3 - mercapto - 2,2 - dimethyl - 1 - oxopropyl) - 4,4 - dimethoxy - L - proline.
Example 33 [7 85] -7 - (3 - Mercapto - 2- ethyl - 1- oxopropyl] - 1,4- dioxo -7- azaspiro[4.4]nonane -8-carboxylic acid a)[7 (5), 8S]-7-[3- (Acetylthio)-2- ethyl - 1- oxopropyl] - 1,4- dioxo -7- azaspiro[4.4]nonane -8carboxylic acid
4,4 - Ethylenedioxy - L- proline is reacted with D - 3 - acetylthio - 2 - ethylpropionyl chloride according to the procedure of Example 1 (e) to give [7 (S), 8S] - 7 [3 - (acetylthio) - 2 - ethyl - 1 - oxopropyl] - 1,4 - dioxo - 7 - azaspiro[4.4]nonane - 8 - carboxylic acid.
b)[7(5),8S]-7-(3-Mercapto-2-ethyl- 1 - oxopropyl) - 1,4- dioxo -7- azaspiro[4.4]nonane -8 carboxylic acid
The product from part (a) is hydrolyzed with con
centrated ammonia according to the procedure of
Example 2 to give [7 (S),8S] - 7 - (3 - mercapto - 2
ethyl - 1 - oxopropyl) - 1,4 - dioxo -7 - azas- piro[4.4]nonane - 8 - carboxylic acid.
Example 34 (S) - 1-(3-Mercapto-2-ethyl- 1- oxopropyl - 4,4 - dimethoxy - L - proline a) (5) - 1- [3 - (Acetylthio) - 2 - ethyl - 1- oxopropyl] 4,4- dimethoxy- L - proline 4,4 - Dimethoxy - L - proline is reacted with D - 3 acetylthio - 2 - ethylpropionyl chloride according to the procedure of Example 3 (d) to give (S) - 1 - [3 (acetylthio) - 2 - ethyl - 1 - oxopropyl] - 4,4 dimethoxy- L- proline.
b) (5)- 1 (3 - (3-Mercapto -2 - ethyl - 1- oxopropyl) - 4,4 - dimethoxy - L - proline
The product from part (a) is hydrolyzed with concentrated ammonia according to the procedure of
Example 4to give (S) - 1 - (3 - mercapto - 2 - ethyl - 1 oxopropyl) - 4,4 - dimethoxy - L - proline.
Example 35 [8S] - 7 - (3- Mercapto - 2- trifluoromethyl - 1 - oxopropyl) - 7 - aza - 1,4 - dithiaspiro[4.4]nonane -8carboxylic acid a) 3- [[(4- Methoxy) phenylmethyl] thio]-2- trifluoromethylpropionyl chloride
A neat mixture of 1 - trifluoromethylacrylic acid (3.9 g.) and 4 - methoxybenzylthiol (4.3 g.) is stirred at 100-110 for one hour. The mixture is allowed to cool to room temperature and the solid is recrystallized from cyclohexane to yield 3 - [[(4 - methoxy) phenylmethyl]thio]- 2 - trifluoromethylpropionic acid; m.p. 72-74 .
Treatment of this acid with thionyl chloride yields 3 - [[(4 - methoxy) phenylmethyl]thio] - 2 - trifluoromethylpropionyl chloride.
b) [8S] - 7 - [3 - [[64 - Methoxy)phenylmethyl]thio] - 2 - trifluoromethyl - 1- oxopropyl] -7 - aza - 1,4- dithiaspiro[4.4]nonane - 8 - carboxylic acid
The 3 - [[(4 - methoxy) phenylmethyl]thio] - 2 trifluoromethyl propionyl chloride from part (a) is reacted with 4,4 - ethylenedithio - L - proline according to the procedure of Example 9 (d) to yield [8S] - 7 - [3 - [[(4 - methoxy) phenylmethyl] thio] - 2 - trif luoromethyl - 1 - oxopropyl] - 7- aza - 1 A - dithiaspiro[4.4] nonane - 8 - carboxylic acid.
c) [8S] - 7 - f3 - Mercapto - 2 - trifluoromethyl - 1- oxopropyl) - 7- aza - 1,4- dithiaspiro[4.4]nonane -8carboxylic acid
The product from part (b) is mixed with trifluoroacetic acid and anisole under nitrogen The solvents are removed under vacuum to yield as a residue [8S] - 7 - (3 - mercapto - 2 - trifluoromethyl - 1 - oxopropyl) - 7 - aza - 1,4 - dithiaspiro[4.4] nonane - 8 - carboxylic acid.
Example 36 [85] -7- (3- Mercapto - 2 - methylthio - 1 - oxopropyl) -7 - aza - 1,4- dithiaspiro[4.4]nonane -8-carboxylic acid a) 3 - [[f4 - Methoxy) phenylmethyl] thio] - 2 - methylthio - propionyl chloride
3 - [[(4 - Methoxy) phenylmethyl] thio] - 2 - methylthiopropanoic acid prepared according to the procedure of Example 10 in U.S. Patent 4,116,962 is tre
ated with thionyl chloride to yield 3 - [[(4 - methoxy)
phenylmethyl] thio] - 2 - methylthiopropionyl chloride.
b) [8S] - 7 - [3 - [[f4 - Methoxy)phenylmethyl] thio] - 2 - methylthio - 1 - oxopropyl] - 7- aza - 1,4- dithias- piro[4.4]nonane - 8 - carboxylic acid
The 3 - [[(4 - methoxy) phenylmethyl] thio] - 2
methylthiopropionyl chlodie from part (a) is reacted with 4,4 - ethylenedithio - L - proline according to the
procedure of Example 9 (d) to yield [8S] - 7 - [3 - [[(4
methoxy) phenylmethyl] thio] - 2 - methylthio - 1 oxopropyl] - 7 - aza - 1,4 - dithiaspiro[4.4]nonane - 8 carboxylic acid.
c) [85] - 7- (3 -Mercapto -2 - methylthio - 1 - oxopropyl) - 7 - aza - 1,4 - dithiaspiro[4.4]nonane - 8 carboxylic acid
The product from part (b) is mixed with trifluoroacetic acid and anisole under nitrogen. The solvents are removed under vacuum to yield as a residue [85] - 7 - (3 - mercapto - 2 - methylthio - 1 - oxopropyl) - 7 - aza - 1,4 - dithiaspiro[4.4]nonane - 8 carboxylic acid.
Example 37 [7(5), 8S] - 7 - (3 - Mercapto - 3 - methyl - 1- oxopropyl) - 1,4 - dioxo - 7 - azaspiro[4.4]nonane - 8 carboxylic acid a)[7(5), 8S]-7-[3 - FAcetylthio) - 3 - methyl - 1 - oxopropyl| - 1,4- dioxo - 7 - azaspiro[4.4]nonane - 8 - carboxylic acid
4,4 - Ethylenedioxy - L - proline is reacted with D - 3
- acetylthio - 3 - methylpropionyl chloride according
to the procedure of Example 1 (e) to yield [7 (S), 8S] 7 -[3 - (acetylthio) - 3 - methyl - 1 - oxopropyl] - 1,4
dioxo - 7 - azaspiro[4.4]nonane - 8 - carboxylic acid.
I C7 (SJ, 8S-7- 13-Mercapto-3- methyl- 1oxopropyl) - 1,4- dioxo -7- azaspiro[4.4]nonane -8carboxylic acid
The product from part (a) is hydrolyzed with concentrated ammonia according to the procedure of
Example 2 to give [7 (S), 8S] - 7 - (3 - mercapto - 3 methyl - 1 - oxopropyl) - 1,4- dioxo - 7 - azas- piro[4.4]nonane - 8 - carboxylic acid.
Example 38 (S)- 1 - (3-Mercapto -3-methyl- 1 - oxopropyl-4,4- dimethoxy - L - proline a) (S) - 1 - [3- (Acetylthie) - 3- methyl - 1 - oxopropyl] -4,4- dimethoxy- I proline 4,4 - Dimethoxy - L - proline is reacted with D - 3 acetylthio - 3 - methylpropionyl chloride according to the procedure of Example 3 (d) to yield (S) - 1 - [3 (acetylthio) - 3 - methyl - 1 - oxopropyl] - 4,4 dimethoxy - L - proline.
b) (S) - 1- 63 - Mercapto - 3 - methyl- 1- oxopropyl - 4,4 - dimethoxy - L - proline
The product from part (a) is hydrolyzed with con
centrated ammonia according to the procedure of
Example 4 to yield (S) - 1 - (3 - mercapto - 3 - methyl
1 - oxopropyl) - 4,4 - dimethoxy - L - proline.
Example 39 1 - (3- Mercapto - 1- oxopropyl) - 4,4 - dimethylthio
L-proline a) 4 - Keto - L - proline, hydrobromide
To 4.0 g. (0.015 mole) of N - carbobenzyloxy - 4 keto - L- proline are added 20 ml. of hydrogen bromide in acetic acid (30-32%). The mixture is frequently swirled over a period of eight minutes. At the end of th is period (effervescence has stopped), the yellow-orange solution is layered over with 25 of ether, triturating the gummy product. The ether is discarded and the resulting tacky solid is triturated with fresh ether and finally with 50 ml. of acetonitrile to give 4 - keto - L - proline, hydrobromide as a crystalline solid weighing 2.7 g. (85%), m.p. 153-155 (dec.,), [2e -49' (c, 1% in water).
b) 1 -[3- FAcetylthio - 1 -oxopropyl] -4-oxo -L proline
A stirred solution of 4.1 g. (0.0195 mole) of 4 - keto - L - proline, hydrobromide in 50 ml. of water is cooled to 5" and treated portionwise with solid sodium carbonate (foaming is controlled by adding a few drops of ether) to pH 8.0 (approx. 2 g. required).
Then while continuing stirring and cooling, a solution of 3.5 g. (0.012 mole) of 3 - acetylthiopropanoyl chloride in 5 ml. of ethyl acetate is added portionwise by means of a pipette while maintaining the pH at 7.0-8.0 by dropwise addition of 25% (w/v) sodium carbonate solution (about 10 ml.). After about 10 minutes the pH stabilizes at 8.0-8.4. After continued stirring and cooling for a total of 1 hour, the solution is washed with ethyl acetate (2 x 50 ml.), layered over with 50 ml. of ethyl acetate, stirred, cooled, acidified carefully with concentrated hydrochloric acid to pH 2.0, saturated with sodium chloride, and the layers are separated. The aqueous phase is extracted with additional ethyl acetate (3 x 50 ml.), the combined organic layers dried (MgSO4) and the solvent evaporated, finally at 0.2 mm. to give 4.8 g.
of a yellow-orange glass-like residue. This residue is dissolved in 35 ml. of ethyl acetate and treated with a solution of3.5 g. of dicyclohexylamine in 5 ml. of ethyl acetate. On seeding and rubbing, crystalline 1 [3 - (acetylthio - 1 - oxopropyl)] - 4 - oxo - L - proline dicyclohexylamine salt separated, weight after cooling overnight, 2.7 g. (nearly colorless), m.p. 191-193 (dec.), [a]26D24 (c,1% in CHCl2).
This dicyclohexylamine salt is converted to the free acid using potassium bisulfate as described in
Example 1 (e) to give 3.7 g. of 1 -[3-(acetylthio)- 1 oxopropyl] - 4 - oxo - L - proline as a pale yellow glass-like solid.
c) 1- [3- (Acetylthio) - 1- oxopropyl] -4,4- dimethylthio - L - proline The 1 - [3 - (acetylthio) - 1 - oxopropyl] - 4 - oxo - L proline is reacted with methylthiol according to the procedure of Example 9 (a) to yield 1 - [3 - (acetylthio) - 1 - oxopropyl] - 4,4 - dimethylthio - L - proline.
d) 1- (3- Mercapto - 1- oxopropyl) - 4,4 - dimethylthio - L - proline The product from part (a) is hydrolyzed with concentrated ammonia according to the procedure of
Example 2 to yield 1 - (3 - mercapto - 1 - oxopropyl) 4,4- dimethylthio - L - proline.
Example 40 [2(5), 35] -2- (3-Mercapto -2-methyl- 1 -oxop- ropyl)-8,8- dimethyl-6, 10- dioxo -2-azas- piro[4.5]decane - 3 - carboxylic acid a) [2(5), 3S]-2-[3- (Acetylthio)-2- methyl- 1 - oxopropyl] - 8,8 - dimethyl -6,10 - dioxo - 2 - azas pfro[4.5]decane - 3 - carboxylic acid
Utilizing the procedure of Example 1 but substituting 2,2 - dimethyl - 1,3 - propanediol for the ethylene glycol in part (c), one obtains [2 (S), 3S] - 2 - [3 (acetylthio) - 2 - methyl - 1 - oxopropylJ - 8,8 dimethyl - 6,10 - dioxo - 2 - azaspiro[4.5]decane - 3 carboxylic acid.
6) [2 (S 3S]-2-(3- Mercapto -2-n?ethyl-l- oxopropyl) - 8,8 - dimethyl -6,10 - dioxo - 2- azas- piro[4.5]decane - 3 - carboxylic acid
The product from part (a) is hydrolyzed with concentrated ammonia according to the procedure of
Example 2 to yield [2 (S), 3S] - 2 - (3 - mercapto - 2 methyl - 1 - oxopropyl) - 8,8 - dimethyl - 6,10 - dioxo 2 - azaspiro[4.5]decane - 8 - carboxylic acid.
Example 41 [7(5), 8S] - 7 - 63 - mercapto - 2 - methyl - 1- oxopropyl) - 1,4 - dioxo - 7 - azaspiro[4.4]nonane - 2 methyl - 8 - carboxylic acid a) N - Carbobenzyloxy - 4,4 - {1- methylethylenedioxy) - L - proline, methyl ester
A stirred mixture of 8 g. (0.025 mole) of N - carbobenzyloxy - 4,4 - dimethoxy - L - proline, methyl ester, from Example 3a, 2.4 g. (0.032 mole) of 1,2 propanediol, 0.4 g. of p - toluenesulfonic acid monohydrate, and 400 ml. of toluene is heated to reflux (110-112"). The rate of reflux is regulated so that solvent slowly distills by means of a Dean-Stark tube into a graduated cylinder. When 80 ml. of solvent are collected an equal volume of fresh solvent is added to the reaction flask through an addition funnel. This procedure of removing and replacing 80 ml. of solvent is repeated four times during a total reflux period of 1.25 hours.
After standing overnight, the mixture is washed with water. (2 x 100 ml.), the combined washes are back extracted with 100 ml. of toluene, the combined organic layers are dried (MgSO4), and the solvent is removed on a rotary evaporator, finally at 0.2 mm., to give 8.2 g. (99%) of N - carbobenzyloxy - 4,4 - (1 methylethylenedioxy) - L - proline, methyl ester as a yellow viscous oil.
b) N - Carbobenzyloxy - 4,4 - {1- methylethylenedioxy) - L - proline The crude methyl ester product from part (a) (8.2 g., 0.025 mole) is dissolved in 80 ml. of methanol, treated dropwise at into 4 with 18 ml. (0.036 mole) of 2N sodium hydroxide, kept at 0 for one hour, and at room temperature overnight. After removing about half of the solvent on a rotary evaporator, the solution is diluted with 150 ml. of water, washed with 100 ml. of ether (wash discarded), acidified while cooling with 6.3 ml. of 1:1 hydrochloric acid to pH 2, and extracted with ethyl acetate (4 x 75 ml.).
The combined extracts are washed with 50 ml. of saturated sodium chloride, dried (MgSO4), and the solvent evaporated to give 8 g. of a red-orange viscous oil. This oil is dissolved in 50 ml. of acetonitrile, warmed, stirred, and treated with 3.8 g. of 1 adamantanamine. The solid salt rapidly separates.
After cooling overnight, the material is filtered, washed with cold acetonitrile and with ether, and dried in vacuo to yield 10.3 g. of crude adamantanamine salt; m.p. 202-204 (dec.),[a]26D13 (c, 1% in methanol). Following trituration with 50 ml. of
boiling acetonitrile and cooling, the paletan solid salt weighed 9.4 g.; m.p. 202-204 (dec.), [r] 26D -13 (c, 1% in methanol).
The above adamatanamine salt is suspended in 40 ml. of ethyl acetate, stirred, and treated with 1 N hydrochloric acid. When two clear layers are obtained they are separated, the aqueous phase is extracted with additional ethyl acetate (3 x 40 ml.), the combined organic layers are dried (MgSO4), and the solvent evaporated, finally at 0.2 mm. and 40 , to yield 5.8 g. (72%) of N - carbobenzyloxy - 4,4 - (1 methylethylenedioxy) - L- proline as a yelloworange viscous syrup.
c) 4,4 - (1- Methylethylenedioxy) - L - proline A solution of the above N - carbobenzyloxy - 4,4 (1 - methylethylenedioxy) - L- proline (5.6 g., 0.017 mole) in 150 ml. of 2:1 methanol-water is treated with 1.6 g. of 5% palladium-carbon catalyst and shaken under 3 atmospheres of hydrogen for five hours. The catalyst is filtered off under nitrogen, washed with methanol, and the combined filtrates evaporated, finally at 0.1-0.2 mm. to give a crystalline residue. The latter is suspended in 200 ml. of methanol and the evaporation repeated.The solid residue is rubbed under ether (evaporation again repeated) to yield 3.0 g. (94%) of pale tan 4,4 - (1 methylethylenedioxy) - L - proline; m.p. 219-221' (dec.); preceded by gradual darkening and sintering; [a] -22' (c,1% in 1:1 ethanol-water).
d) [7 (S) 8S] (S), [7(S)8S]-7-[3 - (Acetylthio) - 2 - methyl - 1- oxopropyl] - 1,4- dioxo - 7 - azaspiro[4.4]nonane -2methyl - 8 - carboxylic acid
The 4,4 - (1 - methylethylenedioxy) - L - proline (2.8 g., 0.015 mole) is reacted with 3.0 g. (0.017 mole) of D - 3 - acetylthio - 2 - methylpropionyl chloride in 40 ml.
of water according to the procedure of Example 1 (e) to give 5.0 g. of a viscous yellow product. The latter is treated with 2.8 g. of dicyclohexylamine in 45 ml.
of ethyl acetate to yield 4.2 g. of nearly colorless [7 (S),8S]-7- [3 - (acetylthio) -2 - methyl - 1 - oxop- ropyl] - 1,4 - dioxo - 7 - azaspiro[4.4] nonane - 2 methyl - 8 - carboxylic acid, dicyclohexylamine salt; m.p. 170-172' (s, 168'); [α]25D -58 ; (c, 1% in ethanol).
Following crystallization from 12 ml. of acetonitrile, the colorless solid salt weighs 3.85 g. (51%); m.p.
170-172 (s. 168'); [a]25 -57', (c,1% in ethanol).
Anal. Calc'd. for: C14H21NOeS C12H22N: C, 60.90;
H, 8.65; N, 5.46; S, 6.26 Found: C, 60.93; H, 8.72; N, 5.43; S, 6.35.
The dicyclohexylamine salt is converted to the free acid by suspending 3.8 g. in ethyl acetate and treating with 45 ml. of 10% potassium bisulfate and stirring until two layers are obtained. After separating, the aqueous phase is extracted with ethyl acetate (4 x 40 ml.), the organic layers are combined, dried (MgSO4) and the solvent evaporated to give 2.5 g.
(51%) of colorless solid [7 (S) 8S] - 7 - [3 - (acetylthio) - 2 - methyl - 1 - oxoprnpyU - 1,4 - dioxo - 7 - azaspiro[4.4] nonane - 2 - methyl - 8 - carboxylic acid, m.p.
65-68 (s.48 ); [ai25D -100', (c, 1% in ethanol).
e)[7(S),8S]-7-(3-mercapto-2-methyl- 1 - oxopropyl) - 1,4- dioxo - 7 - azaspiro[44]nonane -2methyl 8 - carboxylic acid
The product from part (d) is hydrolyzed with concentrated ammonia according to the procedure of
Example 2 to give 2.05 g. of[7 (S), 8S] - 7 - (3 mercapto - 2 - methyl - 1 - oxopropyl) - 1,4 - dioxo -7 - azaspiro[4.4]nonane - 2 - methyl - 8 - carboxylic acid as a viscous colorless oil, [a]25D - 57 (c,1% in ethanol).
Examples 42-75
Following the procedure of Example 41 the dimethoxy substituted compound of Column I (or its alkyl ester) is treated with the diol or dithiol of Column ll to yield the spiro intermediate of column Ill.
Removal of the N - protecting group (and the alkyl ester group) and acylation with the acyl chloride of
Column IV yields the product of Column V which can then be hydrolyzed to the product of Column VI.
Example p q R9 / R10 Ra Re 4 Re (C)t x 11 o1 H2 42 1 1 CH3 H H H2C-C I I sCN3 4a 1 1 H C CO CO H H I a13 a a a 43 1 1 H3C > C z 3 Cli3 H H 1 C113 21 1 sl H H 44 1 1 ,CN20H C313 H H 1 Cii O CZECH 21 1 O O II H 45 1 1 N H CHa H H 1 CH3 Hacc C-CH I H N 46 1 1 5 t /C20s S 3 H 1 /c H C CO 2 2 H H N H 4 1. 1 HZC | 2 H H H 1 5 2 O O H H 48 1 1 02C-CO2 CF3 H H 1 C1 I I O H H H 49 1 1 112C-CO2 H H H H H3CO XCil2 H H N R 50 1 1 H2C-C01-C2O0 3 3 N H 1 O O N N 51 1 1 Ci F3 H H - sero C2H0 CHa 21 1 H H O O N N 52 1 1 N H H H H (3 O O H N H H 53 1 1 H2C- C-CO2SC CO3 H H 1 CHa I I O O if H 54 1 1 H2CC-CH22g? CH3 11 H 1 S S H H CH 2 3 3 1 O O H H o Ctt2 56 1 1 H C N C1l3 3 H 1 cil3 a 11 H a I I 2 S S C1 H H
17 1 1 O20C-0C,H-ICH2)2oi3 3 H - rero"' O O ~ H N SH 1 1 aCo CO3 H H 1 H C CH /CH CH O O N012 59 1 1 O2C- CHCO2Thc\CO3 H H }{ Z CO3 o o H IS 60 1 1 H C- CH2Ti aS3 H H 1 F-Qo S S H H 61 2 1 H2C --H2 CI: 3 ON OH 62 1 2 H2C - 013 al3 H H 1 CO3 OH OH 63 1 2 H2C - 013 CO3 H H 1 C SH SH 64 1 2 CO a 3 H ii 1 Ii CO H2 3 H C CO wak 65 2 1 H2C CO2 CF H H 1 CH3 SH 1 3 66 2 1 2 CO2 H H H I e 1H SH OH 511 67 2 1 H2C- CO-CH2% CH3 li H 1 I I L'0 CO3 68 1 2 CN3 H H H 2 C2115 ON H C a 2 CO3 ;m otl 69 1 2 H3CX CO3 H H - 1CO C1 H C CH2 ON OH 70 1 1 H3C-HC- CO-CO 001 H H 1 CO I -CH say, I H 3 OH OH 71 2 1 H3C - BCFp CH3 H H 1 CHI Ii OH CO 72 2 1 H2C-CO-CO2Jm' CO3 H H 1 013 SH SH 73 1 1 H2CCOCO2J1 CO3 H H 1 aN3 ON ON 74 1 2 H2C -CO2 C2H5 H H 1 ON CO
Examples 75-124
Following the procedure of Example 41 the disubstituted compound of Column I (or its alkyl ester) is treated with a molar equivalent of the alcohol or thiol of Column II to yield the compound shown in Column III. Alternatively, by treating the dimethoxy substituted compound of formula I (or its alkyl ester) with a molar excess of the alcohol orthiol of Column II one obtains the disubstituted compound of Column IV. Removal of the N-protecting group (and the alkyl ester group) from the intermediate of either
Column Ill or IV followed by acylation with the acid chloride of Column V yields the product of Columns
VI and VII, respectively.These compounds can then by hydrolyzed to the products of Columns VIII and
IX, respectively,
Example p q Yl-Rl 2 2 5 R6 R n Rg ~~~~ 11 22 3 e 4 ~ H 75 1 1 -o-aN -S-CH -CO3 H H 1 76 1 1 va3 -SC2Hg -CO3 H H 1 H co-iN-c0 77 1 1 -CO3 -O-i-CH7 H H H 2 aN3 7a 1 1 va 3 -O-t-C H -CO3 -CO3 H 1 79 1 1 -C-CO3 -O-aN2i -CO3 H H 1 C113 Ho 1 1 -o-al3 QCH2--CH3 H H - zero Hl 1 1 -O-CH vaN2i-CCH3 -CO3 H 1 1 al3
Ha 1 1 -o-a 3 -O- (CH2) 2 < ; C1 H 1 83 1 1 -o-a -C-CO2-CP3 -CO3 H H 1 84 1 1 -o-a -o-(aN2Z3iFS-aN3 H CO2 -O-CHJ t5ll H H - CH2 his 1 1 VaN3 2 5 ~aN3 H H 1 { aH 1 F11-CO 80 1 1 CO3 -OCO3-0 3 C 3 86 1 1 total -O- -ICO2I2-irn. -SCO3 H H 1 C2H1 87 1 1 -C-CO N2 vo -CO H H 1 3 2 C 3 23 HO 1 1 QCH- -0-CH2E;} -C2HS H H 1 CO3 as 1 1 -OCO3 -O-CIt27( li H 1l ~ zero cl.3 90 1 1 -0-C2H5 -O-CH2{ -CO3 H H 1 C113 91 1 1 -0CO3 -0012CC13 -at3 H ii 1 Clf3 92 1 1 -0-C2H5 -C-CO Cl H H CH3 I Cii 29 2 3 3 3 93 1 1 -O-CfI -O-CH2Br -CO3 -CO3 ii 1 94 1 1 -0-Cu3 -0-CN2-OH -CO H I aN3 3 3 95 1 1 O0i -CO2CO2CO H H H 2 96 1 1 -0-C2H5 -C-CO-CO2 -CO3 H H 1 C2115 97 1 1 -0-C113 -o-aN2Ql=CH2. H H - zero al3 96 1 1 -C-CO3 -O-CHCICII II H H 1 99 1 1 ~ -al3 a7-C) 3 -ni, H H 1 103 1 1 -O-CHJ C4Hg H H H 1 101 1 1 -O-CZHS -S-CO -CO H H 3 Cii 39 2 3 3 3 102 1 1 total ( 2 -S- ICO2 H H H H 3 03CO, CHI oCH 103 1 1 -O-CH -S-CO2- Cl C?3 H H 1 CH3 104 1 1 -D-C2H5 -S-CH2 H H - zero ar3 Cl3 105 1 1 -O-CH -o-co2J- -CO3 H ii 1 aH3 106 1 1 -C-CO3 -0-ICO2 -SCIl3 H H CH3 107 1 1 -O-CH S a tt gJ 1 S)CHZ -0-CO2-0 iJ -Cl3 H Ii 1
109 1 1 -O-Cllp g H 1X z 1 Sut CH2 a -2 H ii 7 109 1 1 -C-Calls -Co2 H 1l 1 (3(CH2) F 110 1 1 -o-aR -S-CO2-Cii=CH2 H ii ii 1 C113 111 1 1 -o-a 10iaCCCO Ii H - zero CH3 112 2 1 -O-CIs total ~(3 -CO3 H H 1 C113 112 1 2 -O-Cil3 -O- -C-(CO2)2 -CO2 H ii 1 CH3 a 114 1 2 -O-CII -O-CH2 SCH3 H I( H 2 C2O1 115 2 1 -o-al3 -o-cil2! -aI3 H ii 1 116 2 1 OCO -OC113 2 -CF3 H H 1 C113 117 1 2 QCAI -S-CH2-1F2 H ii ii a CH3 118 1 3 cocoa -s-nrzQ -CO2 H H 1 al3 Wlj 119 1 2 C-CO3 ( -S- (CO212-5 2 0 H 1l - zero C113 120 1 2 -o-a C-CO2CC12 H H ii 1 CH3 121 2 1 -o-oS -CO2 -a 3 H H 1 CH3 122 2 1 VaN3 -0-CH20H CO2 H ii 1 123 1 2 total -C-CO2-CCO2 Cila H H 1 C113 124 2 1 -O-CH -S-Cl3 -CO7 H il 1 CH3 Example 125 (S,S,S,5)- 7,7'- [Dithiobis (2-methyl- oxo -3,1 - propanediylJ] bis [1,4 - dioxa - 7- azaspiro[4.4]nonane - 8 - carboxylic acid] [7(S),8S]-7-(3-Mercapto-2-methyl-1 oxopropyl) - 1,4 - dioxo - 7 - azaspiro[4.4] nonane - 8 carboxylic acid (3.0 g., 0.0109 mole) from Example 2 is dissolved in 80 ml. of water and the pH is adjusted to 6.5 with 1N sodium hydroxide. To this stirred solution is added dropwise a total of 11 ml. of 0.5 M iodine solution in 95% ethanol (6.34 g. iodine/50 ml.
solution) while maintaining the pH at 5.5 to 6.5 with 1N sodium hydroxide. After 15 minutes, a trace of excess iodine is removed with dilute sodium thiosulfate and the solution is concentrated to approximately 50 ml., cooled and acidified with 1:1 hydrochloric acid. Methylene chloride (30 ml.) is added and the mixture is saturated with sodium chloride, stirred, and the layers separated. The aqueous phase is extracted with additional methylene chloride (3 x 20 ml.), the combined organic layers dried (MgSO4), and the solvent evaporated, finally at 0.2 mm. The brittle residue is rubbed under ether and the evaporation repeated to give 2.8 g. of a pale yellow solid residue.The material is redissolved in 50 ml. of methylene chloride, washed with water (3 x 10 ml.), the combined aqueous layers back-extracted with 20 ml. of methylene chloride, and the combined layers dried (MgSO4). Evaporation and trituration with ether as above yields 2.2 g. (73%) of cream-colored amorphous solid (S,S,S,S) - 7,7' - [dithiobis (2 methyl - 1 - oxo - 3,1 - propanediyl)] bis [1,4 - dioxo 7 - azaspiro[4.4]nonane - 8 - carboxylic acid]; m.p.
61-63 (foaming), (s.50 ), [α]26D-92 , (c,1% in ethanol).
Anal. Calc'd. for C22H22N2O10S H2O: C, 46.63; H.
6.05; N, 4.94; S, 11.31 Found: C, 46.52; H, 6.29; N, 4.63; S, 10.96.
Example 126 (5,S,S,S)- 7,7'- [Dithiobis (2 - methyl - oxo -3,1 - propanediyl)] bis [7 - aza - 1,4- dithiaspiro[4.4]nonane - 8 - carboxylic acid]
[7 (S), 8S] - 7 - (3 - Mercapto - 2 - methyl - 1 oxopropyl) - 7 - aza - 1,4 - dithiaspiro[4.4] nonane - 8 carboxylic acid from Example 10 is reacted with iodine according to the procedure of Example 125 to yield (S,S,S,S) - 7,7' - [dithiobis (2 - methyl - 1 - oxo 3,1 - propanediyl)] bis[7 - aza - 1,4- dithias- piro[4.4]nonane - 8 - carboxylic acid].
Example 127 (S,S,S,S)- 1,1'- [Dithiobis (2-methyl- oxo -3,1 - propanediylJ] bis [4,4- dimethoxy - L - proline]
(S) - 1 - (3 - Mercapto - 2 - methyl - 1 - oxopropyl) 4,4 - dimethoxy - L - proline from Example 4 is reacted with iodine according to the procedure of
Example 125 to yield (S,S,S,S) - 1,1' - [dithiobis (2 methyl - 1 - oxo - 3,1 - propanediyl)] bis]4,4 dimethoxy- L- proline].
Example 128 [7 (S -7-[3-(Acetylthio)-2.methyl- 1- oxopropyl - 1,4- dioxo - 7 - azaspiro[4.4]nonane -8carboxylic acid, methyl ester
A solution of the product of Example 1 in ether is treated with a slight excess of diazomethane. After
standing at room temperaturefortwo hours, the solvent is evaporated to give [7(S), 8S1 - 7 - [3 - (acetylthio) - 2 - methyl - 1 - oxopropyl - 1,4 - dioxo 7 - azaspiro[4.4jnonane - 8 - carboxylic acid, methyl ester.
Example 129 [7(5), 8S] - 7- - t3 - Mercapto -2-methyl- 1 -oxop- ropyl) - 1,4- dioxo - 7 - azaspiro[4.4]nonane -8carboxylic acid, methyl ester
The product from Example 128 is hydrolyzed with concentrated ammonia according to the procedure of Example 2 to yield [7 (S), 88] - 7 - (3 - mercapto - 2 methyl - 1 - oxopropyl) - 1,4 - dioxo - 7 - azaspiro[4.4] nonane - 8 - carboxylic acid, methyl ester.
Example 130 (S)- 1 - [3 - (Acetylthio)-2 -methyl- 1 - oxopropyl] 4,4- dimethoxy - L - proline, methyl ester
A solution of the product from Example 3 in ether is treated with a slight excess of diazomethane. After standing at room temperature, the solvent is evaporated to give (S) - 1 - [3 - (acetylthio) - 2 - methyl - 1 oxopropyl] - 4,4 - dimethoxy - L - proline, methyl ester.
Example 131 (S)- 1 {3 - (3-Mercapto -2-methyl- 1 - oxopropyl)-4,4 - dimethoxy - L - proline, methyl ester
The product from Example 130 is hydrolyzed with concentrated ammonia according to the procedure of Example 4 to yield (S) - 1 - (3 - mercapto - 2 methyl - 1 - oxopropyl) - 4,4 - dimethoxy - L - proline, methyl ester.
Example 132 [7 85] - 7 - {3 - Mercapto -2-methyl- 1 oxop- ropyl) - 1,4- dioxo - 7 - azaspiro[4.4]nonane -8carboxylic acid, sodium salt
A solution of 1.0 g. of the product of Example.2 is dissolved in 10 ml. of water and treated with one equivalent of sodium bicarbonate. The solution is freeze-dried to give [7 (S), 8S] - 7 - (3 - mercapto - 2 methyl - 1 - oxopropyl) - 1,4 - dioxo - 7 - azaspiro[4.4] nonane - 8 - carboxylic acid, sodium salt.
In a similar manner, by employing potassium bicarbonate the corresponding potassium salt is obtained.
Example 133 (S)- 1 - 63 - Mercapto -2 - methyl- 1 - oxopropyl) - 4,4 - dimethoxy - L - proline, sodium salt
A solution of 1.0 g. of the product of Example 4 is dissolved in 10 ml. of water and treated with one equivalent of sodium bicarbonate. The solution is freeze-dried to give (S) - 1 - (3 - mercapto - 2 - methyl - 1 - oxopropyl) - 4,4 - dimethoxy - L - proline, sodium salt.
In a similar manner, by employing potassium bicarbonate the corresponding potassium salt is obtained.
Example 134
1000 tablets each containing the following ingredients:
[7 (S) ssJ - 7 - (3 - Mercapto - 2 - methyl - 1 oxopropyl) - 1,4 - dioxo - 7 - azaspiro[4.4jnonane - 8 carboxylic acid 100 mg.
Corn starch 50 mg.
Gelatin 7.5 mg.
Avicel (microcrystalline cellulose) 25 mg.
Magnesium stearate 2.5 mg.
185 mg.
are prepared (from sufficient bulk quantities) by mixing the [7 (S) 8S] - 7 - (3 - mercapto - 2 - methyl - 1 oxopropyl) - 1,4 - dioxo - 7 - azaspiro[4.4jnonane - 8 carboxylic acid and corn starch with an aqueous solution of the gelatin. The mixture is dried and ground to a fine powder. The Avicel and then the magnesium stearate are admixed with granulation. This mixture is then compressed in a tablet press to form 1000 tablets each containing 100 mg. of active ingredient.
Example 135
Tablets each containing 100 mg. of (S) - 1 - (3 mercapto - 2 - methyl - 1 - oxopropyl) - 4,4 dimethoxy - L- proline are produced as described in
Example 134.
Example 136
1000 tablets each containing 50 mg. of[7 (S), 8S] 7 - (3 - mercapto - 2 - methyl - 1 - oxopropyl) - 1,4 - dioxo - 7 - azaspiro[4.4] nonane - 8 - carboxylic acid are produced from the following ingredients [7 (S), 8S] - 7 - (3- mercapto -2 - methyl - 1 - oxop- ropyl) - 1,4 - dioxo - 7 - azaspiro[4.4] nonane - 8 carboxylic acid 50 g.
Lactose lOOg.
Avicel 150g.
Corn starch 50 g.
Magnesium stearate 5 g.
The[7 (S), 8S] -7 -[3 - mercapto- 2 - methyl - 1 - oxopropyl) - 1,4 - dioxo - 7 - azaspiro[4.4] nonane - 8 - carboxylic acid, lactose, and Avicel are admixed, then blended with the corn starch. Magnesium stearate is added. The dry mixture is compressed in a tablet press to form 1000 355 mg. tablets each containing 50 mg. of active ingredient. The tablets are coated with a solution of Methocel E 15 (methyl cellulose) including as a color a lake containing yellow #6.
Example 137
Tablets each containing 50 mg. of (S) - 1 - (3 mercapto - 2- methyl - 1 - oxopropyl) - 4,4 dimethoxy- L- proline are produced as described in
Example 136.
Example 138
Two piece #1 gelatin capsules each containing 100 mg. of[7 (S), 8S] - 7 - (3 - mercapto - 2 - methyl - 1 - oxopropyl) - 1,4 - dioxo - 7 - azaspiro[4.4]nonane - 8 - carboxylic acid, sodium salt, are filled with a mixture of the following ingredients: [7 (S), 8S] - 7 - (3 - mercapto - 2 - methyl - 1 - oxop- ropyl) - 1,4 - dioxo - 7 - azaspiro[4.4]nonane - 8 - carboxylic acid, sodium salt 100 mg.
Magnesium stearate 7 mg.
Lactose 193 mg.
Example 139
Gelatin capsules containing 100 mg. of (S) - 1 - (3 mercapto -2 - methyl - 1 - oxopropyl) - 4,4 dimethoxy - L - proline, sodium salt are produced as described in Example 138.
Example 140
An injectable solution is produced as follows: [7(5), 85] - 7 - (3 - Mercapto - 2 - methyl - 1 - oxop- ropyl) - 1,4 - dioxo - 7 - azaspiro[4.4]nonane - 8 carboxylic acid 500 g.
Methyl paraben 5 g.
Propyl paraben 1 g.
Sodium chloride 25 g.
Water for injection qs. 5 1.
The active substance, preservatives and sodium chloride are dissolved in 3 liters of water and then the volume is brought up to 5 liters. The solution is filtered through a sterile filter and aseptically filled into pre-sterilized vials which are then closed with pre-sterilized rubber closures. Each vial contains 5 ml. of solution in a concentration of 100 mg. of active ingredient per ml. of solution for injection.
Example 141
An injectable solution containing (S) - 1 - (3 - mercapto - 2 - methyl - 1 - oxopropyl) - 4,4 - dimethoxy - L - proline is prepared as described in Example 140.
Example 142
6000 tablets each containing the following ingredients: [7 (5)88] - 7 - (3 - mercapto - 2 - methyl - 1 - oxop- ropyl) - 1,4 - dioxo - 7 - azaspiro[4.4] nonane - 8 carboxylic acid 100 mg.
Avicel (microcrystalline cellulose) 100 mg.
Hydrochlorothiazide 12.5 mg.
Lactose U.S.P. 113 mg.
Corn starch U.S.P. 17.5 mg.
Stearic acid U.S.P. 7 mg.
350 mg.
are produced from sufficient bulk quantities by slugging the [7 (S), 8S] - 7 - (3 - mercapto - 2 - methyl - 1 oxopropyl) - 1,4 - dioxo - 7 - azaspiro[4.4] nonane - 8 - carboxylic acid, Avicel and a portion of the stearic acid. The slugs are ground and passed through a #2 screen, then mixed with the hydrochlorothiazide, lactose, corn starch and remainder of the stearic acid. The mixture is compressed into 350 mg. capsule shaped tablets in a tablet press. The tablets are scored for dividing in half.
Example 143
Tablets each containing (S) - 1 - (3 - mercapto - 2 methyl - 1 - oxopropyl) - 4,4 - dimethoxy - L - proline and hydrochlorothiazide can be prepared as described in Example 142.
The product of Examples 1,3 and 6 to 133 can also be formulated according to the procedures of Exampies 134-143.
Claims (27)
1. Acompound oftheformula
or such a compound in pharmaceutically acceptable salt form wherein
R is hydrogen or lower alkyl;
R1 and R2 are independently selected from the group consisting of lower alkyl, lower alkenyl, lower alkynyl, cycloalkyl, halo substituted lower alkyl, hydroxy substituted lower alkyl,
or R and R2 join together in a polymethylene chain of the formula
X1, X2 and X3 are independently selected from the group consisting of oxygen and sulfur; R2 and R4 are independently selected from the group consisting of hydrogen, lower alkyl, lower alkylthio,-(CH2)n-SH, and halo substituted lower alkyl;; Re is hydrogen or lower alkyl provided that R6 is lower alkyl only when R2 is lower alkyl;
m is zero, one or two;
n is one, two orthree;
p and q are each both or two provided that both are not two; t is two orthree; R7 is hydrogen, lower alkyl of 1 to 4 carbons, lower alkoxy of 1 to 4 carbons, lower alkylthio of 1 to 4 carbons, chloro, bromo, fluoro, trifluoromethyl, or hydroxy;; R9 and R10 are both hydrogen, both lower alkyl, or one is hydrogen and the other is lower alkyl, halo substituted lower alkyl, hydroxy substituted lower alkyl,
R0 is hydrogen, a hydrolyzably removable protecting, a chemically removable protecting group, or provided that neither R2 or R4 is -(CH2)n-SH
2. The compound of Claim 1 wherein p is two and q is one.
3. The compound of Claim 1 wherein p is one and q is two.
4. The compound of Claim 1 wherein p and q are both one.
5. The compound of Claim 4 wherein X, and X5 are independently selected from the group consisting of oxygen or sulfur; R is hydrogen or lower alkyl;
R, and R2 each is lower alkyl of 1 to 4 carbons or form two joined methylene groups; R2 and R4 each is hydrogen or lower alkyl of 1 to 4 carbons; R0 is hydrogen, lower alkanoyl of 1 to 4 carbons, or benzoyl; Re is hydrogen, and m is zero or one.
6. The compound of Claim 4 wherein X, and X2 each is oxygen; R, R4, R5 and Re each is hydrogen; R, and Ra each is lower alkyl of 1 to 4 carbons or R, and Ra each is methylene and join to complete the ethylenedioxy ring; R2 is methyl; and m is one.
7. The compound of Claim 4 wherein X,-R, and X2-R2 complete an ethylenedioxy ring.
8. A compound of the formula
or a pharmaceutically acceptable salt thereof, wherein
R is hydrogen or lower alkyl;
R, and R2 are independently selected from the group consisting of lower alkyl, lower alkenyl, lower alkynyl, cycloalkyl, halosubstituted lower alkyl, hydroxy substituted lower alkyl,
or R, and R2 join together in a polymethylene chain of the formula
X1, Xa and X2 are independently selected from the group consisting of oxygen and sulfur; Ra and R4 are independently selected from the group consisting of hydrogen, lower alkyl, lower alkylthio, -(CH2)5-SH, and halo substituted lower alkyl;; R6 is hydrogen or lower alkyl provided that R6 is lower alkyl only when R2 is lower alkyl;
m is zero, one or two;
n is one, two, orthree;
t is two orthree;
R7 is hydrogen, lower alkyl of 1 to 4 carbons, lower alkoxy of 1 to 4 carbons, lower alkylthio of 1 to 4 carbons, chloro, bromo, fluoro, trifluoromethyl, or hydroxy;; R9 and R15 are both hydrogen, both lower alkyl, or one is hydrogen and the other is lower alkyl, halo substituted lower alkyl, hydroxy substituted lower alkyl,
R9 is hydrogen, a hydrolyzably removable protecting group, a chemically removable protecting group, or provided that neither Ra nor R4 is -(CH2)n-SH
9.The compound of Claim 8 wherein R is hydrogen; R4 is hydrogen; R2 and Re are both lower alkyl of 1 to 4 carbons or R6 is hydrogen and R2 is hydrogen, lower alkyl of 1 to 4 carbons, trifluoromethyl, methylthio, or mercaptomethyl; R5 is hydrogen, lower alkanoyl of 1 to 4 carbons, or benzoyl; X1 and
X2 are oxygen or sulfur; R, and R2 are lower alkyl of 1 to 4 carbons,
m is zero or one; and R7 is hydrogen, methyl, methoxy, methylthio, chloro, bromo, fluoro, trifluoromethyl, or hydroxy.
10. The compound of Claim 9 wherein R is hydrogen; R4 is hydrogen; R2 and Re are both methyl or R6 is hydrogen and R2 is hydrogen, methyl, trifluoromethyl, methylthio, or mercaptomethyl; R5 is hydrogen, acetyl, or benzoyl; X, and Xa are the same; R, and Ra are methyl, ethyl,
m is zero or one; and R7 is hydrogen, methyl, methoxy, methylthio, chloro, bromo, fluoro, trifluoromethyl or hydroxy.
11. The compound of Claim 10 wherein R, R4, R5, and R6 are hydrogen; Ra is methyl; m is one; and R, and Ra are both methyl or ethyl.
12. The compound of Claim 11 wherein X, and X5 are both oxygen.
13. The compound of Claim 12, (S) - 1 - (3 - mer capto - 2 - methyl - 1 - oxopropyl) - 4,4 - dimethoxy - L -proline.
14. The compound of Claim 12, (S) - 1 - (3 - mer capto - 2 - methyl - 1 - oxopropyl) - 4,4 - diethoxy - L - proline.
15. The compound of Claim 8 wherein R is hydrogen; R4 is hydrogen; R2 and R6 are both lower alkyl of 1 to 4 carbons or R6 is hydrogen and Ra is hydrogen, lower alkyl of 1 to 4 carbons, trifluoromethyl, methylthio, or mercaptomethyl; R5 is hydrogen, lower alkanoyl of 1 to 4 carbons, or benzoyl; X,-R, and Xa-Ra join to form
R9 and R15 are both hydrogen or both lower alkyl of 1 to 4 carbons; or R9 is hydrogen and R15 is lower alkyl of 1 to 4 carbons, hydroxy substituted lower alkyl of 1 to 4 carbons, or halogen substituted lower alkyl of 1 to 4 carbons; m is zero or one.
16. The compound of Claim 15 wherein R9 and R,o are both hydrogen or R5 is hydrogen and R10 is methyl, hydroxymethyl, ortrifluoromethyl.
17. The compound of Claim 16 wherein R is hydrogen; R4 is hydrogen; R2 and Re are both methyl or Rg is hydrogen and R2 is hydrogen, methyl, trifluoromethyl, methylthio or mercaptomethyl; R1 is hydrogen, acetyl, or benzoyl; and X,-R, and X2-R2 join to form
18. The compound of Claim 17 wherein R, R4, R5 and Re are hydrogen, R2 is methyl; and m is one.
19. The compound of Claim 18, [7(8), 88] - 7 - (3 - mercapto - 2 - methyl - 1 - oxopropyl) - 1,4 - dioxo - 7 azaspiro[4.4]nonane - 8 - carboxylic acid.
20. The compound of Claim 18,[2(S),3S]-2-(3- mercapto - 2 - methyl - 1 - oxopropyl) - 6,10 - dioxo - 2 - azaspiro[4.5]decane - 3 - carboxylic acid.
21. The compound of Claim 18, [7 (S), 8S] - 7 - (3 mercapto-2- methyl-i -oxopropyl)-7-aza- 1,4 - dithiaspiro[4.4]nonane - 8 - carboxylic acid.
22. The compound of Claim 18,[7(S),8S]-7-(3 - mercapto - 2 - methyl - 1 - oxopropyl) - 1,4 - dioxo - 7 azaspiro[4.4]nonane - 2 - methyl - 8 - carboxylic acid.
23. The compound of Claim 17 wherein R, R4, R1 and R0 are hydrogen, R2 is trifluoromethyl; and mis one.
24. The compound of Claim 23, (8S) - 7 - (3 - mercapto - 2 - trifluoromethyl - 1 - oxopropyl) - 1,4 dioxo - 7 - azaspiro[4.4]nonane - 8 - carboxylic acid.
25. The compound of Claim 8 wherein R2 and R4 areotherthan-(CHa)n-SH and R5is
26. The compound of Claim 25, (S,S,S,S) - 7,7'
dithiobis (2 - methyl - 1 - oxo - 3,1 - propanediyl)] bis 1,4 - dioxo - 7- azaspiro[4.4]nonane - 8 - carboxylic acid].
27. A process for preparing a compound of the formula
or a pharmaceutically acceptable salt thereof, wherein
R is hydrogen or lower alkyl;
R, and R2 are independently selected from the group consisting of lower alkyl, lower alkenyl, lower alkynyl, cycloalkyl, halo substituted lower alkyl, hydroxy substituted lower alkyl,
or R1 and Ra join together in a polymethylene chain of the formula
X1, X2 and X2 are independently selected from the group consisting of oxygen and sulfur; R2 and R4 are independently selected from the group consisting of hydrogen, lower alkyl, lower alkylthio,-(CH2)n-SH, and halo substituted lower alkyl;;
R6 is hydrogen or lower alkyl provided that Re is lower alkyl only when R2 is lower alkyl;
m is zero, one or two;
n is one, two orthree;
p and q are each both ortwo provided that both are not two;
t is two or three;
R7 is hydrogen, lower alkyl of 1 to 4 carbons, lower alkoxy of 1 to 4 carbons, lower alkylthio of 1 to 4 carbons, chloro, bromo, fluoro, trifluoromethyl, or hydroxy;; R9 and R10 are both hydrogen, both lower alkyl, or one is hydrogen and the other is lower alkyl, halo substituted lower alkyl, hydroxy substituted lower alkyl,
R5 is hydrogen, a hydrolyzably removable protecting, a chemically removable protecting group, or provided that neither R3 orR4is-(CH2)0-SH
characterised by: :
(1) coupling a substituted proline or pipecolic acid of the formula
with an acid of the formula
wherein R'5 is hydrogen or a hydrolyzably or chemically removable protecting group, according to conventional methods, or
(2) treating a compound of the formula
wherein R's is hereinabove defined with alcohols or thiols selected from the group consisting of R,X,H, R2X2H and
to form a product wherein R1 is hydrogen or a hyd roiyzably or chemically removable protecting group, and removing said protecting group to form a product wherein Rs is hydrogen, and oxidizing said products wherein R1 is hydrogen to form the product wherein R5 is
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US97231478A | 1978-12-22 | 1978-12-22 |
Publications (2)
Publication Number | Publication Date |
---|---|
GB2039478A true GB2039478A (en) | 1980-08-13 |
GB2039478B GB2039478B (en) | 1983-02-16 |
Family
ID=25519507
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB7942991A Expired GB2039478B (en) | 1978-12-22 | 1979-12-13 | Mercaptoacyl derivatives of pyrrolidines or piperidenes |
Country Status (31)
Country | Link |
---|---|
JP (1) | JPS5594357A (en) |
AT (1) | AT374174B (en) |
AU (1) | AU533149B2 (en) |
BE (1) | BE880815A (en) |
CA (1) | CA1132985A (en) |
CH (1) | CH642065A5 (en) |
CS (1) | CS215036B2 (en) |
DD (1) | DD148338A5 (en) |
DE (1) | DE2951200A1 (en) |
DK (1) | DK159115C (en) |
ES (2) | ES8102094A1 (en) |
FI (1) | FI70886C (en) |
FR (1) | FR2444669A1 (en) |
GB (1) | GB2039478B (en) |
GR (1) | GR78384B (en) |
HK (1) | HK15684A (en) |
HU (1) | HU179644B (en) |
IE (1) | IE49321B1 (en) |
IL (1) | IL58930A (en) |
IT (1) | IT1126841B (en) |
LU (1) | LU82023A1 (en) |
NL (1) | NL7909246A (en) |
NO (1) | NO153569C (en) |
NZ (1) | NZ192449A (en) |
PH (1) | PH19213A (en) |
PL (1) | PL133414B1 (en) |
PT (1) | PT70620A (en) |
SE (1) | SE451839B (en) |
SU (1) | SU1115668A3 (en) |
YU (1) | YU314879A (en) |
ZA (1) | ZA796720B (en) |
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4311705A (en) * | 1980-10-06 | 1982-01-19 | E. R. Squibb & Sons, Inc. | Carboxyalkanoyl and hydroxycarbamoylalkanoyl derivatives of substituted prolines |
US4325943A (en) | 1980-05-02 | 1982-04-20 | E. R. Squibb & Sons, Inc. | Mixed disulfides |
US4332725A (en) * | 1979-12-29 | 1982-06-01 | Egyt Gyogyszervegyeszeti Gyar | Process for the preparation of 1-[3-mercapto-(2S)-methylpropionyl]-pyrrolidine-(2S)-carboxylic acid |
US4356182A (en) * | 1979-10-22 | 1982-10-26 | E. R. Squibb & Sons, Inc. | Mercaptoacyl derivatives of 4-disubstituted prolines |
US4374131A (en) | 1981-04-27 | 1983-02-15 | E. R. Squibb & Sons, Inc. | Amino and substituted amino phosphinyl-alkanoyl compounds |
US4452790A (en) * | 1982-06-23 | 1984-06-05 | E. R. Squibb & Sons, Inc. | Phosphonyl hydroxyacyl amino acid derivatives as antihypertensives |
US4452791A (en) * | 1982-03-15 | 1984-06-05 | E. R. Squibb & Sons, Inc. | Aminoalkyl and related substituted phosphinic acid angiotensin converting enzyme inhibitors |
US4462943A (en) * | 1980-11-24 | 1984-07-31 | E. R. Squibb & Sons, Inc. | Carboxyalkyl amino acid derivatives of various substituted prolines |
US4555506A (en) * | 1981-12-24 | 1985-11-26 | E. R. Squibb & Sons, Inc. | Phosphorus containing compounds and use as hypotensives |
US4560680A (en) * | 1982-03-15 | 1985-12-24 | E. R. Squibb & Sons, Inc. | Aminoalkyl and related substituted phosphinic acid angiotensin converting enzyme inhibitors |
US4567166A (en) * | 1982-07-14 | 1986-01-28 | E. R. Squibb & Sons, Inc. | Amino and substituted amino phosphinylalkanoyl compounds useful for treating hypertension |
US4616005A (en) * | 1982-06-23 | 1986-10-07 | E. R. Squibb & Sons, Inc. | Phosphonyl hydroxyacyl amino acid derivatives as antihypertensives |
US4703043A (en) * | 1982-06-23 | 1987-10-27 | E. R. Squibb & Sons, Inc. | Phosphonyl hydroxyacyl amino acid derivatives as antihypertensive |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2455585A1 (en) * | 1979-05-04 | 1980-11-28 | Ono Pharmaceutical Co | OXOAMINOACID DERIVATIVES, MANUFACTURING METHOD AND PHARMACEUTICAL COMPOSITION |
US4288368A (en) * | 1979-07-30 | 1981-09-08 | E. R. Squibb & Sons, Inc. | Dithioacylproline derivatives |
US4291040A (en) * | 1979-10-22 | 1981-09-22 | E. R. Squibb & Sons, Inc. | Mercaptoacyl derivatives of 4-disubstituted prolines and 4-substituted dehydroprolines |
US4316905A (en) * | 1980-07-01 | 1982-02-23 | E. R. Squibb & Sons, Inc. | Mercaptoacyl derivatives of various 4-substituted prolines |
US4416831A (en) | 1981-04-27 | 1983-11-22 | E. R. Squibb & Sons, Inc. | Amino and substituted amino phosphinylalkanoyl compounds |
US4381297A (en) | 1981-05-04 | 1983-04-26 | E. R. Squibb & Sons, Inc. | Substituted carbonyl phosphinyl-alkanoyl compounds |
US4416833A (en) | 1981-05-04 | 1983-11-22 | E. R. Squibb & Sons, Inc. | Substituted carbonyl phosphinyl-alkanoyl compounds |
CA1258853A (en) * | 1982-04-30 | 1989-08-29 | Rudiger D. Haugwitz | Substituted 4-phenoxy prolines |
US4709046A (en) * | 1983-05-09 | 1987-11-24 | E. R. Squibb & Sons, Inc. | Acylmercaptoalkanoyl and mercaptoalkanoyl spiro compounds |
CA2021409A1 (en) * | 1989-08-21 | 1991-02-22 | Donald S. Karanewsky | Phosphonate substituted amino or imino acids useful as antihypertensives |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4046889A (en) * | 1976-02-13 | 1977-09-06 | E. R. Squibb & Sons, Inc. | Azetidine-2-carboxylic acid derivatives |
US4091024A (en) * | 1976-12-03 | 1978-05-23 | E. R. Squibb & Sons, Inc. | Pyrrolidine and piperidine-2-carboxylic acid derivatives |
IT7851510A0 (en) * | 1977-10-28 | 1978-10-16 | Sandoz Ag | AMIDES OF CYCLIC AMINO ACIDS THEIR PREPARATION AND THEIR APPLICATION AS MEDICINES |
PH15381A (en) * | 1978-02-21 | 1982-12-17 | Squibb & Sons Inc | Halogen substituted mercaptoacylamino acids |
CA1144930A (en) * | 1978-08-11 | 1983-04-19 | Miguel A. Ondetti | Mercaptoacyl derivatives of substituted prolines |
-
1979
- 1979-12-07 CA CA341,486A patent/CA1132985A/en not_active Expired
- 1979-12-11 ZA ZA00796720A patent/ZA796720B/en unknown
- 1979-12-11 AU AU53714/79A patent/AU533149B2/en not_active Ceased
- 1979-12-12 IL IL58930A patent/IL58930A/en unknown
- 1979-12-13 GB GB7942991A patent/GB2039478B/en not_active Expired
- 1979-12-13 GR GR60746A patent/GR78384B/el unknown
- 1979-12-17 CS CS798891A patent/CS215036B2/en unknown
- 1979-12-18 NZ NZ192449A patent/NZ192449A/en unknown
- 1979-12-19 IE IE2468/79A patent/IE49321B1/en unknown
- 1979-12-19 DE DE19792951200 patent/DE2951200A1/en not_active Ceased
- 1979-12-19 PH PH23434A patent/PH19213A/en unknown
- 1979-12-19 NO NO794181A patent/NO153569C/en unknown
- 1979-12-19 FR FR7931132A patent/FR2444669A1/en active Granted
- 1979-12-20 AT AT0805479A patent/AT374174B/en active
- 1979-12-20 CH CH1133979A patent/CH642065A5/en not_active IP Right Cessation
- 1979-12-20 SE SE7910550A patent/SE451839B/en not_active IP Right Cessation
- 1979-12-21 LU LU82023A patent/LU82023A1/en unknown
- 1979-12-21 IT IT51167/79A patent/IT1126841B/en active
- 1979-12-21 YU YU03148/79A patent/YU314879A/en unknown
- 1979-12-21 ES ES487180A patent/ES8102094A1/en not_active Expired
- 1979-12-21 DD DD79218061A patent/DD148338A5/en not_active IP Right Cessation
- 1979-12-21 HU HU79SU1047A patent/HU179644B/en not_active IP Right Cessation
- 1979-12-21 PL PL1979220609A patent/PL133414B1/en unknown
- 1979-12-21 BE BE0/198709A patent/BE880815A/en not_active IP Right Cessation
- 1979-12-21 FI FI794027A patent/FI70886C/en not_active IP Right Cessation
- 1979-12-21 SU SU792860149A patent/SU1115668A3/en active
- 1979-12-21 PT PT70620A patent/PT70620A/en unknown
- 1979-12-21 NL NL7909246A patent/NL7909246A/en not_active Application Discontinuation
- 1979-12-21 DK DK550079A patent/DK159115C/en not_active IP Right Cessation
- 1979-12-22 JP JP16747179A patent/JPS5594357A/en active Pending
-
1980
- 1980-02-20 ES ES488752A patent/ES8103039A1/en not_active Expired
-
1984
- 1984-02-23 HK HK156/84A patent/HK15684A/en unknown
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4356182A (en) * | 1979-10-22 | 1982-10-26 | E. R. Squibb & Sons, Inc. | Mercaptoacyl derivatives of 4-disubstituted prolines |
US4332725A (en) * | 1979-12-29 | 1982-06-01 | Egyt Gyogyszervegyeszeti Gyar | Process for the preparation of 1-[3-mercapto-(2S)-methylpropionyl]-pyrrolidine-(2S)-carboxylic acid |
US4325943A (en) | 1980-05-02 | 1982-04-20 | E. R. Squibb & Sons, Inc. | Mixed disulfides |
US4325944A (en) | 1980-05-02 | 1982-04-20 | E. R. Squibb & Sons, Inc. | Mixed disulfides |
US4325945A (en) | 1980-05-02 | 1982-04-20 | E. R. Squibb & Sons, Inc. | Mixed disulfides |
US4311705A (en) * | 1980-10-06 | 1982-01-19 | E. R. Squibb & Sons, Inc. | Carboxyalkanoyl and hydroxycarbamoylalkanoyl derivatives of substituted prolines |
US4462943A (en) * | 1980-11-24 | 1984-07-31 | E. R. Squibb & Sons, Inc. | Carboxyalkyl amino acid derivatives of various substituted prolines |
US4374131A (en) | 1981-04-27 | 1983-02-15 | E. R. Squibb & Sons, Inc. | Amino and substituted amino phosphinyl-alkanoyl compounds |
US4555506A (en) * | 1981-12-24 | 1985-11-26 | E. R. Squibb & Sons, Inc. | Phosphorus containing compounds and use as hypotensives |
US4452791A (en) * | 1982-03-15 | 1984-06-05 | E. R. Squibb & Sons, Inc. | Aminoalkyl and related substituted phosphinic acid angiotensin converting enzyme inhibitors |
US4560680A (en) * | 1982-03-15 | 1985-12-24 | E. R. Squibb & Sons, Inc. | Aminoalkyl and related substituted phosphinic acid angiotensin converting enzyme inhibitors |
US4452790A (en) * | 1982-06-23 | 1984-06-05 | E. R. Squibb & Sons, Inc. | Phosphonyl hydroxyacyl amino acid derivatives as antihypertensives |
US4616005A (en) * | 1982-06-23 | 1986-10-07 | E. R. Squibb & Sons, Inc. | Phosphonyl hydroxyacyl amino acid derivatives as antihypertensives |
US4703043A (en) * | 1982-06-23 | 1987-10-27 | E. R. Squibb & Sons, Inc. | Phosphonyl hydroxyacyl amino acid derivatives as antihypertensive |
US4567166A (en) * | 1982-07-14 | 1986-01-28 | E. R. Squibb & Sons, Inc. | Amino and substituted amino phosphinylalkanoyl compounds useful for treating hypertension |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2039478A (en) | Derivatives of mercaptoacyl pyrrolidines or piperidines | |
US4311697A (en) | Derivatives of mercaptoacyl prolines and pipecolic acids | |
US4217359A (en) | Carbamate derivatives of mercaptoacyl hydroxy prolines | |
US4578474A (en) | Imido, amido and amino derivatives of mercaptoacyl prolines and pipecolic acids | |
US4390695A (en) | Imido, amido and amino derivatives of mercaptoacyl prolines and pipecolic acids | |
US4192945A (en) | Process for preparing proline and homoproline derivatives | |
US4296113A (en) | Mercaptoacyl derivatives of keto substituted proline and pipecolic acid | |
US4757069A (en) | Pyridazodiazepine derivatives | |
SK50695A3 (en) | Hydroxame derivatives acid with tricyclic substituents | |
EP0018104B1 (en) | Tetrahydroisoquinolines, their production and the compounds and pharmaceutical compositions containing them for use in the prevention or treatment of hypertension | |
US4296033A (en) | 4-Azido-1-mercaptoacyl proline | |
US4225495A (en) | Pyrrolo or pyrido [2,1-c][1,4] thiazines or thiazepines | |
US4291040A (en) | Mercaptoacyl derivatives of 4-disubstituted prolines and 4-substituted dehydroprolines | |
US4252943A (en) | Carbamate derivatives of mercaptoacyl hydroxy prolines | |
US4709046A (en) | Acylmercaptoalkanoyl and mercaptoalkanoyl spiro compounds | |
US4330548A (en) | Mercaptoacyl derivatives of keto substituted pipecolic acid | |
US4456761A (en) | 4-Substituted dehydroprolines | |
CA1138452A (en) | Carbamate derivatives of mercaptoacyl hydroxy prolines | |
ISAKA et al. | Lactol esters of ampicillin | |
US4499287A (en) | Certain-4-hydroxy-proline derivatives | |
GB2070586A (en) | Derivatives of Proline or Pipecolic Acid | |
US4356182A (en) | Mercaptoacyl derivatives of 4-disubstituted prolines | |
CA1138878A (en) | Mercaptoacyl derivatives of keto substituted proline and pipecolic acid | |
US4377701A (en) | 4-Methylene-1-[[(alranoyl or arylcarbonyl)mercapto]acyl]proline and pipecolic acid | |
FI80675B (en) | Azabicycloalkane carboxylic acid derivatives and a process for the preparation thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PCNP | Patent ceased through non-payment of renewal fee |